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Antimicrobial peptides (AMPs) are small chains of amino acids with the ability
to cause bacterial death. AMPs are usually amphiphilic but diverse in charge and
structure. The mechanism or mechanisms that AMPs implement to kill bacteria
are still under discussion. Studies in model membranes have widely demonstrated
the capacity of AMPs to interact with and disrupt the bacterial cell membrane.
There are however, good reasons to suspect that AMP interactions with non-
membrane components of bacteria are important. For instance, there is an enor-
mous discrepancy between the peptide to lipid molar ratio (P:L) necessary to
generate membrane disruption in model systems (∼ 1:100), and the P:L necessary
to stop bacterial growth, i.e. the minimal inhibitory concentration (MIC) (∼ 10-
100:1). One potential explanation for this discrepancy is that AMPs may interact
with non-membrane components of the bacterial cell envelope. The peptidoglycan
(PGN) layer is one of the primary non-membrane components of Gram-positive
bacterial cell envelopes and is responsible for cell shape and stability. Currently,
there is an open discussion about whether PGN can entrap AMPs and prevent
them from reaching the cell membrane or, instead promote the accumulation of
AMPs on the cell membrane. The primary experimental approach employed in
this thesis was 2H NMR spectroscopy of intact bacteria with 2H-labeled mem-
branes. Specifically, since the quadrupolar splittings obtained from the spectra
are proportional to the order parameter of the lipid acyl chains, the spectra reflect
the structure and dynamics of the membrane. In particular, 2H NMR spectroscopy
allows us to characterize the disruption of lipid bilayers caused by AMPs. In this
study, different methods to grow 2H-membrane-enriched bacteria were optimized
to obtain 2H NMR spectra of E. coli LA8, E. coli JM109 and B. subtilis. Addi-
tionally, 2H NMR was used to observe the level of disruption of the cell membrane
of B. subtilis caused by the presence of different AMPs, MSI-78 and BP100. Both
MSI-78 and BP100 caused the same level of membrane disruption at similar con-
centrations. Separately, comparison of the 2H NMR spectra of B. subtilis with
intact and compromised PGN layers showed no differences. The lack of change in
the spectra of PGN-compromised and PGN intact bacteria indicates that there is
no change in the dynamics or structure of the lipid bilayer even with a weakened
PGN layer. Finally, the disruption caused by MSI-78 and BP100 was measured in
ii
B. subtilis with a compromised PGN layer. The results indicate that there is no
change in the level of membrane disruption caused by MSI-78 and BP100 when
the PGN layer is partially removed.
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Chapter 1
Overview
Antimicrobial peptides (AMPs) are chains of amino acids with the ability to kill
pathogens, such as bacteria, fungi and viruses. They may also kill cancer cells.
At the same time AMPs should cause little or no harm to host cells. The mech-
anism or mechanisms that AMPs implement to kill those pathogens is still under
study. The main results regarding AMPs can be divided into results obtained from
studies of model systems and results obtained in biological experiments. Model
systems are phospholipid bilayers intended to mimic the bacterial membrane com-
position. From the study of model systems it is widely accepted that, in the case
of bacteria, AMPs interact with and disrupt the bacterial cell membrane [2–4].
On the other hand, biological experiments have shown the ability of AMPs to
inhibit bacterial growth over a wide spectrum of bacterial species. One way to
establish a connection between the results from model system experiments and
biological experiments is to extend the techniques used in model systems to whole
cells. AMPs’ disruption of lipid structures make 2H nuclear magnetic resonance
(NMR) an appealing technique to study their effects on fluidity of phospholipid
acyl chains. The quadrupolar splitting in the deuterium magnetic resonance spec-
trum is related to the orientational order parameter of the lipid acyl chains. As a
consequence, 2H NMR spectra can be used to glean information about the molec-
ular dynamics of the system and therefore the physical state of lipid assemblies
can be determined [5]. In particular, 2H NMR can be useful to identify changes
to the lipid membrane state caused by AMPs. Because the natural abundance of
1
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2H atoms is 0.01%, 2H NMR measurements in bacterial cells require the bacte-
ria to be deuterium-labeled. Our group and others have developed methods that
promote the uptake of deuterium-labeled acyl chains in bacterial cells to produce
2H-membrane-enriched bacteria [1, 6–8]. In my thesis, changes in the 2H NMR
spectrum of different bacterial strains in the presence and absence of different
AMPs are used to obtain information about how the peptides interact with and
disturb bacterial membranes. This work is also intended address recent questions
about whether the peptidoglycan (PGN) layer has a role on the AMP-lipid bilayer
interaction [12, 108]. Such questions arise from the fact that bacterial cell envelopes
also have non-lipid components located outside of the phospholipid membrane.
Chapter 2
Introduction
To achieve a better understanding of this project, some concepts need to be intro-
duced. First, background on Gram + and Gram - bacterial cell envelopes and their
primary differences will be described. Next will be a discussion of what AMPs are
and why it is important to understand their ability to kill pathogens and, espe-
cially bacteria. Finally, essential information about 2H NMR in lipid bilayers will
be provided, followed by discussion of why this technique is implemented to study
the dynamics of the AMP-lipid bilayer interaction and how to interpret 2H NMR
spectra obtained from whole bacterial cells.
2.1 Gram Positive (Gram +) and Gram Negative
(Gram -) Bacterial Cell Envelopes
One of the most important bacterial organelles is the cell envelope. Some of the
many bacterial cell envelope functions are: to separate the interior of the bacteria
from the environment; to enable the transport of substances and information be-
tween the outside and the inside; to enable metabolism, growth and multiplication;
and to provide structural stability to the cell [9].
3
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Figure 2.1: Gram - and Gram + cell envelope content
Although all structures in the bacterial cell envelope are adapted to enable the
functions explained above, each species of bacteria accomplishes the same objec-
tives in different ways. This makes the bacterial envelope a very complex organelle
that varies with different bacteria types. Even so, there are structural components
that are common to many or most of them. For example, structures such as a lipid
bilayer and a peptidoglycan layer are essential components of the cell envelope of
ALL bacteria, providing a barrier in the lipid bilayer case, and stability in the
peptidoglycan case [9].
In 1884, Gram discovered a way to differentiate bacteria into two types using a
staining method. Depending on the structure of the cell envelope, bacteria will
retain a different amount of Gram’s dye. Bacteria that stain with a dark blue to
violet color are called Gram positive (Gram +) and bacteria that stain with a red
color are called Gram negative (Gram -). The difference in color is due to the
differences in the cell envelope composition between these two kinds of bacteria.
Both of them have a peptidoglycan (PGN) layer but in Gram + bacteria this
layer is much thicker than in Gram - bacteria. Also, Gram - bacteria have a
second membrane with the inner leaflet composed of lipids and the outer leaflet
containing Lipopolysaccharides (LPS) (See Figure 2.1)[9].
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In order to clearly define the difference between Gram + bacteria and Gram -
bacteria, the main components of the bacterial membrane will be explained first.
2.1.1 Phospholipids
The most common lipids in cells are the phospholipids. Phospholipids display
a variety of charges, acyl chain lengths, and unsaturations. They are essential
for the bacterial envelope, determining its structure and flexibility. In bacterial
membranes, phospholipid composition depends on bacterial species and environ-
mental conditions [10]. Typically, however, about 25% of the bacterial envelope
consists of phospholipids and between 1-5% of the bilayer consists of cardiolipin,
a glycerolphospholipid, whose role is also important for the bacterial bilayer [9].
The principal characteristic of phospholipids is their amphiphilic nature. They
have two structural components, a hydrophobic hydrocarbon chain and a polar
head group, which may be zwitterionic or may carry overall charge. Due to the
dual interaction of phospholipids with water molecules, phospholipids tend to form
bilayer or micellar structures consisting of a hydrocarbon nucleus and an external
surface formed by polar heads [9]. Phospholipid bilayer structures have different
phase states. The two more studied are the gel and the liquid-crystalline states.
The gel phase is an ordered state in which lateral mobility is slow and the phospho-
lipid acyl chains tend to be extended. In contrast, in the liquid-crystalline phase,
lateral mobility is higher than in the gel state and the phospholipid acyl chains are
less ordered than in the gel state. The liquid crystal-gel phase transition tempera-
ture depends on the phospholipid chemical structure. For instance, phospholipids
with longer acyl chains typically have higher phase transition temperature. Unless
otherwise, noted, the term "lipids" will refer to "phospholipids" throughout this
thesis.
2.1.2 Lipopolysaccharides (LPS)
Like other components of the cell envelope, LPS are amphiphilic molecules with
a positive charge. LPS molecules are combinations of lipids and polysaccharides,
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which allows them to vary in size and structure, especially in the hydrophilic
polysaccharide part. LPS is present in the outer leaflet of the outer membrane of
Gram - bacteria along with lipid A, and it is essential for Gram - bacteria [9].
2.1.3 Peptidoglycan
The polymer responsible for the stability of the bacterial shape and for preventing
expansion of the cell membrane under hypertonic conditions is called peptido-
glycan (PGN). The PGN polymer is composed of alternating units of N-acetyl
glucosamine (NAG) and N-acetyl muramic acid (NAM). PGN polymers are cross-
linked by pentapeptide side chains (see Figure 2.2). The resulting structure is
considered a highly rigid net. Depending on the kind of bacteria, the percentage
of PGN composing the cell wall mass could vary from ∼ 10% for Gram - bacteria
to 90 % for Gram + bacteria [9].
Figure 2.2: Schematic illustration of the Gram + cell wall and cell membrane.
Lipid headgroups are represented by green circles, and hydrophobic acyl chains
in black. The PGN structure is composed of alternating NAG-NAM (pink and
beige) cross-linked by pentapeptide side chain in light blue. The LTA is repre-
sented as TA units, in orange, anchored to the cell membrane with two diglycosyl
groups, in blue, and a glycolipid in red.
Introduction 7
2.1.4 Teichoic Acid (TA)
Along with the PGN, teichoic acids (TAs) are an important part of the Gram +
bacterial cell wall. Teichoic acids can be grouped into lipoteichoic acids (LTAs) and
wall teichoic acids (WTAs). The main difference between LTA and WTA is that
LTA is anchored to the cell membrane via a glycolipid while WTA is covalently
anchored to the N-acetylmuramic acid (NAM) of the PGN [11, 12]. However,
both LTA and WTA have positive and negatively charged groups, but, are overall
negativelly charged [11]. LTAs and WTAs are usually both present at the same
time and there is at least four different classes of teichoic acids. TAs consist of
repeating units of water soluble polymers, which may vary in length between Gram
+ species [12]. In the case of B. subtilis, one of the bacterial strains used in my
study, LTA is composed of 23 units of glycerol-phosphate, forming a polymer of
approximately 4900 g/mol [13]. TAs are important for the bacterial shape and the
regulation of cell division [12]. Unlike phospholipids, pure LTA in aqueous solution
do not form stable monolayer structures but are able to form micellar structures
[12].
In summary, Gram + and Gram - bacteria have a cytoplasmic membrane, which in
both classes is the inner layer of the bacterial envelope. The cytoplasmic membrane
is principally composed of lipids, mainly phospholipids, as well as sugars and
proteins. Additionally, both classes of bacteria have a periplasmic space, which
contains the PGN web. However, the outer envelope of Gram - bacteria is made
of a single layer of PGN that makes the periplasmic space of Gram - bacteria
smaller than the one in Gram +, which is made of many layers of PGN. Finally,
the presence of an outer membrane in Gram - bacteria is another major difference
between those bacterial types. The outer membrane is composed mainly of lipids
in the internal leaflet and lipopolysaccharides in the outer leaflet.
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2.2 Antimicrobial Peptides (AMPs)
All living creatures are in permanent contact with diverse types of microorganisms.
Many of these microorganisms are pathogens, which means that these microorgan-
isms can potentially cause infection and disease. Living organisms have developed
different mechanisms to protect themselves from pathogenic microorganisms. One
of those mechanisms is the production of AMPs.
AMPs are amino acid chains, i.e. polypeptides, of usually between 10 and 50
amino acids, with the ability to kill microbes. To date, over 3000 amino acid
sequences have been identified or predicted to be AMPs [14]. Studies of AMPs have
increased dramatically over the last 30 years. This is not surprising since there is a
desperate interest to find novel antimicrobial agents in the face of the emergence of
antibiotic resistant bacterial strains [15]. Research into AMPs includes discovery,
characterization of their structure, design of new AMPs, and attempts to explain
the mechanisms that AMPs use to kill bacteria.
As mentioned above, AMPs are one of the responses of the immune systems of
different living organisms to pathogen threats. Some characteristics that most
of the AMPs share are short amino acid chain length, positive overall charge,
structures with both hydrophobic and hydrophilic sections and selectivity [16].
The amphiphatic characteristic of AMPs makes them prone to interact with the
amphiphilic cytoplasmic membrane of bacteria. Selectivity in AMPs refers to
their ability to inhibit the growth of pathogens at AMP concentrations that do
not harm host cells [17]. Selectivity is commonly explained as a consequence of the
positive charge of AMPs that allows them to bind to negatively charged bacterial
membrane surfaces more strongly than to the host cells, which are usually neutral
in charge [4].
Understanding the whole mechanism or mechanisms that AMPs employ to kill
bacteria is imperative to full understanding of AMPs and, perhaps, to the use
of AMPs as fully functional antibiotic replacements. Different aspects of AMPs
have been studied in order to explore various hypotheses about AMP mechanisms.
One approach has been to focus on the amino acid sequences (i.e. the primary
structure) and secondary structures of AMPs, and on how specific AMP structures
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are correlated with the effectiveness of such peptides. AMPs are diverse in amino
acid sequence and secondary structure. AMPs with α-helix, β-sheet, random coil
or disordered secondary structures can be commonly found, as well as peptides
with cyclic sequences or even disulfide cross links [16, 18, 19]. The very diversity
of AMP structures suggests that they may function via a range of mechanisms
and that structure-function relationships might not be generalized across the vast
number of AMPs [20–22].
Another aspect of AMPs that has been extensively studied is the permeabilizing
effect that AMPs have on the lipid bilayer of the bacterial membrane [23]. The
permeabilization is usually associated with the ability of AMPs to make pores
and/or to cross the membrane lipid bilayer [24–27]. This permeabilizing effect
on the lipid bilayer can rupture the bacterial membrane which can lead to cell
disintegration, also known as lysis. There are a number of proposed models that
may explain the permeabilizing effect of AMPs on the lipid bilayer [16, 23, 28, 29].
Those models can be separated into pore and non-pore models. Pore models state
that once AMP monomers reach the lipid bilayer, they can generate membrane-
spanning pores large enough to allow water and ions to exchange between the
cell interior and exterior. Different shapes of pores have been proposed, such as
toroidal or barrel stave pores. Non-pore models are more diverse. Most of them
require high peptide concentrations over the membrane and propose various effects
such as changes in the lipid packing, lipid clustering or even collapse of the lipid
bilayer (See Figure 2.3). All of these models have been extensively studied in
lipid bilayers composed of a small number of lipid types, that are highly simplified
models of the cytoplasmic membrane of bacteria. Such studies generally support
the conclusion that AMPs are able to compromise the lipid bilayer integrity, an

















Figure 2.3: Collection of cartoons illustrating different models that could ex-
plain the permeabilizing effect of AMPs on lipid membranes. (a) Absorption of
the AMP into the lipid membrane. (b) Carpet model. (c) Barrel stave model.
(d) Translocation. (e) Membrane thinning. (f) Toroidal pore. (g) Disordered
toroidal pore. Lipid headgroups are represented by yellow circles and hydropho-
bic acyl chains in black. In this picture, the same cationic AMPs are presented in
two different ways: A disordered structure (just before absorption) represented
as black curved lines, and α-helical structures (after absorption) represented by
blue cylinders.
It is clear that the overall positive charge and the hydrophobic composition of
AMPs underlie their ability to interact with negative lipid bilayers such as the
cytoplasmic membrane of bacteria. However, recent studies have found evidence of
AMPs translocating across the membrane and also interacting with other bacterial
components that lie inside the cell, such as ribosomes, DNA, RNA, enzymes and
chaperone proteins [29–32]. Such AMPs could be inhibiting cell wall synthesis,
nucleic acid synthesis, protein synthesis and enzymatic activity, any of which could
be lethal for bacteria [33]. Those findings make it necessary to re-evaluate whether
the permeabilizing effect of the AMPs is the only mechanism that AMPs use to
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kill bacteria or if the AMPs’ permeabilizing effect is just one component of a
multi-target mechanism for killing bacteria.
Some studies such as the one performed by He et al. in 2014 [34], have failed to
detect a direct correlation between the lytic effect of AMP on lipid vesicles and
AMP-induced cell death. Also, in 2006, William C. Wimley [16] pointed out the
enormous difference between the peptide to lipid ratio in microbe sterilization ex-
periments (as high as P:L=1000:1)1, and in a typical vesicle leakage experiment
(P:L=1:100). One possible explanation for this discrepancy could be that model
systems, such as lipid vesicles, are an oversimplification of the bacterial cell en-
velope. Model systems lack important components of the bacterial membrane
such as proteins embedded in the lipid bilayer, a peptidoglycan (PGN) layer and
lipopolysaccharides (LPS). As a result, one new question arises: Are the non-lipid
components of the bacterial cell envelope relevant for understanding AMPs’ effects
on the bacterial cell envelope’s lipid bilayer?
It is thus necessary build a bridge that connects the historical work regarding
AMPs interacting with model lipid bilayers to the relatively recent finding that at
least some AMPs act on non-lipid targets. One approach is to extend the same
techniques used to perform experiments in model systems to whole bacterial cells.
That involves adapting those biophysical techniques for use in whole bacterial
cells.
Biophysical techniques for studying membrane-peptide model systems are diverse
and can be used to examine different characteristics of the AMP-lipid bilayer inter-
actions. Neutron scattering, for example, is sensitive to changes in the scattering-
length densities within the lipid bilayer, which means that it can be used to de-
tect the presence of water molecules inside the lipid bilayer, especially if those
molecules are passing through the bilayer due to the presence of a pore [35, 36].
X-ray crystallographic measurements can be used to determine the structure of
the AMPs in different environments such as, for example, an oriented lipid bilayer
[37]. Lamellar X-ray diffraction can be used to determine the distance between the
1Molar P:L were estimated from the literature. Calculations are explained in Appendix A
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lipid headgroup phosphates located in different leaflets of the bilayer [26]. Small-
angle X-ray scattering (SAXS) can be used to determinate lattice parameters and
phase symmetry changes induced by the presence of AMPs [38].
Fluorescence microscopy and spectroscopy use different kind of probes, lasers,
and forms of data acquisition. For example, fluorescent probes with high water
solubility are often used to measure membrane leakage induced by AMPs [39].
Also, lipid mobility can be measured with techniques such as fluorescence recovery
after photobleaching (FRAP) or single molecule tracking techniques [39]. Like
FRAP, fluorescence correlation spectroscopy (FCS) can be used to measure the
lateral diffusion of lipids. FCS measures the diffusion time of individual fluorescent
molecules in a small volume [40]. The use of this technique in lipid bilayers in
the presence of AMPs has helped to determine changes in the mobility of the
lipids as a result of the presence of AMPs [25]. Circular dichroism (CD) is also
a light spectroscopy technique and is commonly used to determine the secondary
structure of peptides in general. In the case of AMPs, a change in the secondary
structure is often observed when the peptide binds a lipid bilayer [41]. Atomic
force microscopy (AFM) is a technique that can be used to get topological maps
of supported lipid bilayers and to measure the force necessary to pierce the lipid
bilayer with the cantilever tip [42]. In the presence of AMPs, the change in the
integrity of the supported lipid bilayer can be observed [43].
For its part, Nuclear Magnetic Resonance (NMR) has found multiple applications
in the study of AMPs and AMP-bilayer interactions. 1H solution NMR, often
in conjunction with 15N NMR, can be used to determine the structure of AMPs
[44]. 31P NMR is sensitive to AMP-induced changes in the rate and symmetry
of lipid motions in membranes and lipid structures [45]. 2H NMR can be used
to determine lipid membrane phases as well as changes in the lipid orientational
order resulting from contact with AMPs [46].
As mentioned above, one of the ways to connect work on AMPs in model lipid
systems with the real biological AMP/bacteria systems, is to translate these model
system approaches to whole bacteria experiments. Translating these approaches,
however, is usually not easy. Some of the techniques mentioned above can not be
applied to whole bacteria systems because of the complexity of the cell itself, and
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other techniques, like fluorescence microscopy and spectrometry, require the use
of fluorescent probes, usually fluorescent molecules, that can disrupt the system
under study. 2H NMR is one of the techniques that can be performed in whole
cells and just requires the replacement of the hydrogen atoms by deuterium atoms,
which is a minimally perturbing probe. However, implementing 2H NMR in whole
cells is challenging.
Our lab and others have developed methods that promote the uptake of deuterated
acyl chains into the bacterial membrane, resulting in a deuterium-rich lipid bilayer
[1, 6–8]. These methods have been used so far with different mutated and unmu-
tated bacterial strains. In this research, 2H NMR experiments were performed to
observe the changes in the lipid dynamics caused by the presence of two peptides:
MSI-78 and BP100. More information about these peptides is presented next.
2.2.1 MSI-78
Magainin 1 and Magainin 2 belong to a family of peptides isolated from the skin
of an African frog, Xenopus laevis, and reported in 1987 by Michael Zasloff [47].
MSI-78 (also called Pexiganan) is a synthetic analog of Magainin 2 with twenty-two
(22) amino acids. The MSI-78 and Magainin 2 amino acid sequences are provided
in Table 2.1. MSI-78 possesses more potent antimicrobial activities than Magainin
2 [48], but Magainin 2 and MSI-78 both have broad antimicrobial activity against
Gram + and Gram - bacteria. 31P-NMR experiments and differential scanning
calorimetry (DSC) studies suggested changes on the curvature of lipid bilayers
upon the addition of MSI-78. Those changes were consistent with the formation
of toroidal pores similar to the pores formed by Magainin 2 [49]. MSI-78 reached
phase III clinical trials as a treatment for infected foot ulcers affecting diabetic
patients [50]. However, after approval for marketing, it was found that MSI-78
treatments did not prove to be more effective than treatments with regular antibi-
otics [51]. The MSI-78 story underlines the importance of better understanding
how AMPs interact with pathogenic bacteria.
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Table 2.1: Amino acid sequences and characteristics of AMPs used in this
study, and selected related AMPs and toxin (Melittin). Blue color represents




































2.2.2 CAME and BP100
Cecropins are a family of peptides that are part of the immune system of insects.
In particular, cecropin A was isolated for the first time in 1981 when H. Steiner
et al. found it in the immune system of the cecropia moth [52]. Cepropin A has
thirty seven (37) amino acids that are separated into two domains. The N-terminal
domain forms an amphipathic α-helix, while the C-terminus forms a hydrophobic
helix [53].
Melittin is a bee venom toxin composed of twenty six amino acids. The initial
studies about melittin were published in Germany in the 1960’s [54–56]. In contrast
to cecropins, melittin has a hydrophobic N-terminus and a basic C-terminus [53].
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Although melittin’s antimicrobial effect is well known, melittin has a toxic effect
that arises from its ability to lyse, i.e break open, red blood cells.
Chimeric peptides of cecropin A and melittin were designed to increase the antimi-
crobial effect of cecropin A, while at the same time counteracting the toxic effect of
melittin [53]. Hybrids of cecropin A and melittin are most commonly formed with
the first half of cecropin A linked to the first half of melittin. The initial designed
hybrids were approximately twenty six residues, while subsequent hybrids were
considerably smaller (∼ 11 residues) [57]. CAME and BP100 are both chimeric
peptides from cecropin A and melittin. Due to its short amino acid sequence, low
cytotoxicity, low susceptibility to protease degradation, and effectiveness against
plant pathogenic bacteria such as Erwinia amylovora [58, 59], BP100 has potential
to treat multiple plant diseases caused by pathogens at a moderate cost [60]. Bio-
physical studies revealed some details about the membrane permeabilizing effect
caused by BP100 in model membranes. BP100 has a strong selectivity toward
negatively charged lipids and it is able to translocate across lipid bilayers at both
high and low peptide/lipid ratios [60]. The effect of BP100 on the membrane of
E. coli was studied using AFM and zeta potential measurements. It was found
that BP100 is able to cause major damage to the bacterial envelope [61].
2.3 Nuclear Magnetic Resonance
The lipid bilayer of the cell membrane is one of the meeting points between phys-
ical and biological sciences. Understanding its structure and dynamics is key to
revealing the membrane’s biological functions at a molecular level. One of the bio-
physical techniques that allows dynamical properties of lipid bilayers to be studied
without employing labels that may perturb the membrane is 2H NMR.
Nuclear magnetic resonance arises when magnetic nuclei are manipulated by ap-
plication of a radio frequency magnetic field oscillating at a specific frequency
appropriate to the nucleus and applied static field. For 2H NMR of lipid bilayers,
the hydrogen atoms of the lipid’s acyl chains are replaced by deuterium atoms,
which have spin 1 nuclei (See Figure 2.4). This replacement allows measurement
of a particular spectral parameter, the quadrupolar splitting, for those deuterium
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atoms attached to molecular segments undergoing anisotropic reorientations. As a
result of the proportionality between the quadrupolar splitting and an acyl chain
segment property known as the orientational order parameter, 2H NMR is sensi-
tive to the molecular order and motion of the lipid’s acyl chains in a lipid bilayer
or a cell membrane [5, 62]. In particular, 2H NMR can be used to measure the
AMP-induced changes in the distribution of quadrupolar splitting, and thus of
orientational order, along the acyl chain. These changes, in turn, reflect changes
in the physical state of the membrane lipid bilayer.
a) b)
Figure 2.4: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) or 16:0 PC,
structure. a) DPPC is a saturated lipid whose fatty acyl chains are 16 carbons
in length. b) DPPC-d62 is a saturated lipid whose fatty acyl chains are 16
carbons in length and whose acyl chain hydrogen atoms have been replaced
with deuterons.
The theoretical background needed to understand quadrupolar splitting, as well
as the powder pattern lineshapes and their interpretations, follows.
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2.3.1 Deuterium Nuclear Magnetic Resonance
The NMR resonance frequencies satisfy the Planck equation
∆E = hν (2.1)
where, in this system, ∆E is the difference between spin state energies of the
target nucleus in the applied magnetic field, h is the Planck constant and ν is the
resonance frequency. Getting the energies of the system involves solving the time
independent Schrödinger equation.
The deuterium nucleus, known as a deuteron, consists of one proton and one
neutron and thus is a spin 1 particle. As a result, it can exist in one of three
states corresponding to m = −1, m = 0, or m = +1. Because of selection rules,
the allowed transitions are only between adjacent levels so that ∆m = ±1. For
a deuterium nucleus in a C-D bond in the presence of an external magnetic field
( ~B), the Hamiltonian that describes its allowed energy levels can be written as the
sum of Hamiltonians for the significant interactions as:
Ĥ = Ĥo + ĤQ + ĤCS + ĤD (2.2)
where Ĥo is the Hamiltonian due to the Zeeman interaction, ĤQ is the elec-
tric quadrupolar interaction Hamiltonian, ĤCS is the Hamiltonian due to the
anisotropic chemical shift interaction, and ĤD is the Hamiltonian due to the
dipolar interaction that arises from the interaction between two magnetic dipole
moments.
The significance of each interaction is decided by its magnitude relative to the
quadrupolar coupling. The maximum quadrupolar splitting value for a deuterium
nucleus in a static C-D bond is 250 kHz, the chemical shift interaction for a deu-
terium nucleus is ∼ 1 kHz, and the frequency for the dipolar interaction between
two deuterium nuclei is ∼ 4 kHz. As a result, the chemical shift interaction and
the dipolar interactions can be neglected, [62], and the equation 2.2 can be written
as:
Ĥ = Ĥo + ĤQ (2.3)
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[63]. The eigenvalues for the Zeeman Hamiltonian, Ĥo, can be written as
EZm = −gmβNB (2.4)
where B, is the magnitude of the external magnetic field ~B, g is the gyromagnetic
factor, βN the nuclear magneton, and m is the magnetic quantum number.
As described by Davis in 1983 [62] and Seelig in 1977 [63], the eigenvalues for the
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where eq is the magnitude of the C-D bond electric field gradient at the nucleus, eQ
is the electric quadrupole moment of the deuteron, I is the spin quantum number
and η is the asymmetry parameter. The orientation of the C-D bond, in the frame
of reference of the electric field gradient tensor principal axis system, is defined by
β′ and α. β′ is the angle between the C-D bond vector and the direction of the
magnetic field ~B (along the z axis) and α is the angle between the projection of
the C-D bond vector onto the x-y plane and the y axis (See Figure 2.5). So, the
total energy Em for the quadrupolar and the Zeeman interaction (Ĥo + ĤQ) is:
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[62]. The selection rule for transitions between spin states only allows ∆m = ±1
so the allowed transitions are
hν+ = E−1 − E0 (2.7)










Figure 2.5: Schematic representation of the orientation of the bilayer normal
and the C-D bond orientation in the x, y, and z plane. β defines the angle
between the magnetic field (z axis) and the bilayer normal. θ defines the angle
between the bilayer normal and the C-D bond vector. β′ defines the angle
between the magnet field and the C-D bond vector, and α defines the angle
between the projection of the C-D bond vector onto the x-y plane and the y
axis.











































Figure 2.6: Schematic representation of the Zeeman effect and the Zeeman
effect plus quadrupolar interaction on energy levels of the deuterium nucleus
and on the resulting 2H NMR spectra.
[63]. Both ν+ and ν− are composed of two terms. The first one arises from
the Zeeman effect, νo, and the second one is from the quadrupolar interaction,
∆νQ. The Zeeman effect alone generates a single peak centred at νo, the Larmor
frequency. The Zeeman effect plus the quadrupolar interaction however, generates
two peaks centered at frequencies νo ± (∆νQ)/2 (See Figure 2.6). The difference














where e2qQ/h is called the quadrupolar coupling constant and is 167 kHz for C-D
bonds [64]. Because the electric field gradient for C-D bonds is nearly symmetric
with respect to the bond direction, the asymmetry parameter, η, is approximately










For the case of a deuterium atom in a C-D bond, the primary contributions to the
electric field gradient are due to the molecular electronic distribution. Because of
that, the angles β′ and α change as a result of molecular motion. For fluid phase
bilayers, those motions occur on a timescale short in comparison with 1/∆νQ so










Because the C-D bond is attached to the lipid’s acyl chains in a lipid bilayer and
the lipid bilayers are structures with a specific symmetry, a change in the frame of
reference is helpful. The frame of reference so far is the electric field gradient tensor
principal axis system, which describes the system in spherical coordinates with the
angles defined above. The change in the frame of reference is accomplished with
the Wigner rotation matrices and corresponds to the separation of β′ into two
angles: the angle between the bilayer normal with respect to the z axis, β, and
the angle of the C-D bond vector with respect to the bilayer normal, θ. In terms












The averaged factor in equation 2.13 depends on the amplitude of motion for the
C-D bond with respect to the bilayer normal. The distribution of β depends on
sample geometry. In the case of unilamellar or multilamellar vesicles, the bilayer
normals are randomly oriented and β will range between 0◦ and 90◦, where 0◦ rep-
resents lipids in bilayers with normals oriented parallel or antiparallel to the mag-
netic field (i.e. toward the poles of a spherical distribution of directions) and 90◦
represents lipids in bilayers with normals oriented perpendicular to the magnetic
field (i.e. toward the equator of a spherical distribution of directions). Because a
random distribution of bilayer normal directions is more heavily weighted toward
equatorial orientations, a largest intensity is expected for splittings corresponding
to β = 90◦. As a result, the 2H NMR spectrum has a characteristic line shape
known as Pake doublet that is shown in Figure 2.7. Notice that the Pake doublet
in this figure, like all of the 2H NMR spectra shown in this thesis, is plotted so
that the center of the spectrum (ν0) corresponds to zero frequency. Each branch
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1/2 ≤ |x| ≤ 1 (2.14)
with x = 2ν/∆νQ. The spectrum is symmetric about the origin when both
branches are included.
Figure 2.7: Schematic representation of the powder pattern spectrum of a
vesicle with a unique C-D bond. The black lines represent the separation of the
powder spectrum in two branches (one solid and one dashed) corresponding to
the two deuteron transitions. The blue line is the sum of the two peaks which
results in the powder pattern spectrum of a C-D bond.

















The average in equation 2.16, is over reorientations of the C-D bonds with re-
spect to the bilayer normal, i.e. axially symmetric motions, occurring during the
timescale of the measurements (timescale shorter than 1/∆νQ). SCD scales the
splitting of the Pake doublet spectrum.
The amphiphilic nature of lipids determines their natural dynamics. In fluid or
liquid crystalline phase bilayers, acyl chain carbons close to the polar head group
tend to have a movement with smaller amplitude than the ones at the middle of the
lipid bilayer. This behavior leads to larger orientational order parameters on C-D
bonds close to the head group in comparison with C-D bonds close to the ends of
the acyl chains. In vesicles with randomly oriented bilayers of chain-perdeuterated
lipids, the 2H NMR spectrum has the shape shown in black inside the red square
of Figure 2.8. This is a superposition of Pake doublets with splittings for each
acyl chain segment, ranging from larger values corresponding to chain segments
near the lipid headgroup, to smaller values for segments near the chain ends. The
purple spectrum inside the red square of Figure 2.8 is the result of transforming
(dePaking) the "powder" spectrum to obtain the spectrum that would have been
obtained if all of the bilayer normals had been aligned perpendicular to the mag-
netic field. Notice that the quadrupolar splittings, ∆νQ, of the first five C-D bonds
are very similar.
The orientational order profile of a lipid assembly is the set of orientational or-
der parameters corresponding to the different segments on the lipid acyl chains
plotted as a function of the position along the chain. It can be obtained from the
spectra of specifically deuterated phospholipids [65] or an approximation can be
obtained from an oriented 2H NMR spectrum or a dePaked spectrum [66]. Due
to the proportionality between the orientational order parameter, SCD, and the
quadrupolar splitting, ∆νQ, the orientational order parameter for each carbon po-
sition, SCD(n), can be extracted from the quadrupolar splitting of each doublet.
A sample order profile obtained from the dePaked spectrum of DPPC-d62 at 42◦
C from Figure 2.8 is shown in Figure 2.9. In the dePaked spectrum shown in
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Figure 2.8: Schematic representation of the powder pattern spectrum (black)
and the dePaked spectrum (purple) of a vesicle sample with multiple C-D bonds
(miltilamellar vesicles of DPPC-d62 at 42◦ C prepared as explained in section
3.7). Larger splittings represents the C-D bonds closer to the lipid head groups.
Numbers in the figure indicate the deuterated chain segment corresponding to
each peak in the spectrum.
Figure 2.8, the doublets from segments 7-16 are resolved. Doublets from segments
2-6, on the other hand, have very similar splittings values. Thus, splittings for
C-D bonds close to the headgroup are unresolved and form a constant line, in the
order parameter profile, that is referred as the "plateau" region and is shown by
the box in Figure 2.9. It should be noted that the orientational order parameter
of chain segments in the plateau region are approximated as being constant due
to the corresponding doublets being unresolved. In fact, specific labeling shows
that the splittings for deuterons of carbon two can be smaller than for deuterons
on other chain segments so that the actual profile is not flat in the plateau region
[65].
2.3.2 Understanding 2H NMR Spectra of Bacterial Mem-
branes
As explained above, model system studies are typically intended to mimic the
cytoplasmic membrane of bacteria, but the diversity of lipid headgroups and acyl
chains in cell membranes makes this very difficult. In the case of 2H NMR model
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Figure 2.9: Order parameter profile of DPPC at 42◦ C (Obtained from mul-
tilamellar vesicles of DPPC-d62 prepared as explained in section 3.7). The box
indicates the plateau region.
studies, perdeuterated phosphatidylcholines (PC) with zwitterionic head groups
are often mixed with negatively charged phosphatidylglycerol (PG) in different
proportions in order to mimic the intrinsic negative charge of the bacterial mem-
brane. Additionally, different model membranes can be employed, for example,
multilamellar vesicles, mechanically-oriented bilayers or magnetically-oriented bi-
celles.
Unlike single-component model membranes, where all lipid molecules undergo
the same motions, bacterial membranes have a complex composition. Addition-
ally, deuterium-labeling techniques can not guarantee the same lengths for all the
deuterated acyl chains on the lipids. As a result, spectra of membrane deuterated
bacteria do not display individual doublets that can be assigned to particular C-D
bonds undergoing axially symmetric reorientations (See Figure 2.10) but rather,
show a lineshape that is a function of the distribution of splittings. Nonetheless,
the spectral lineshape does allow identification of quadrupolar splitting values for
some of the C-D bonds close to the head group that give rise to the plateau in the
orientational order parameter profile for bilayer lipids. This can be observed in
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the 2H NMR spectrum of bacterial samples as prominent edges (p in Figure 2.10).
Additionally, the end of the acyl chain can be recognized by the methyl peak (m
in Figure 2.10). Because of the natural amount of deuterium in water and the low
signal available from deuterated bacterial membranes, it is normal to also see a
narrow water peak at the centre of the spectrum (w in Figure 2.10).
Figure 2.10: 2H spectrum of E. coli enriched with deuterated acyl chains.
Arrows to indicate: the prominent edges (p) that correspond to the quadrupole
splitting of C-D bonds close to the lipid’s head group, methyl deuteron doublet
(m) that corresponds to quadrupole splitting of C-D bonds close to the center
of the lipid bilayer, and the water peak (w).
Prominent edges help to define the plateau region in the orientational order param-
eter. From them, Stockton et al. [67] and Davis et al. [68] reported (SCD)plateau
values of approximately 0.2 for Acholeplasma laidlawii at 42◦ C and 0.26 for E.
coli L51 at 37◦ C respectively. (SCD)plateau values of ∼ 0.2 were reported for 1,2-
dilauroyl-d46-sn-glycero-3-phosphocholine (DLPC-d46) at 30◦ C, 1,2-dimyristoyl-
d54-sn-glycero-3-phosphocholine (DMPC-d54) at 30◦ C, DPPC-d62 at 50◦ C and
1,2-distearoyl-d70-sn-glycero-3-phosphocholine (DSPC-d70) at 65◦ C by Petrache
et al. in 2000 (See Figure 2.11), [69]. Thus, considering that the liquid crystal-gel
phase transition temperature for pure DLPC is -2◦ C, pure DMPC is 24◦ C, pure
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DPPC is 41◦ C and pure DSPC is 55◦ C, (SCD)plateau values of ∼ 0.2 are typical
of phospholipid liquid-crystalline phase.









































































































Figure 2.11: Order parameter profile obtained from the dePaked 2H NMR
spectra of DLPC-d46, DMPC-d-54, DPPC-d62 and DSPC-d70 at different tem-
peratures. Data for sn-1 and sn-2 chains are shown separately. Order pa-
rameter profiles obtained from the ∆νQ values reported in Area per Lipid and
Acyl Length Distributions in Fluid Phosphatidylcholines Determined by 2H NMR
Spectroscopy, Biophys. J. 79: 3172-3192. by Petrache, H.I., S.W. Dodd, and
M.F. Brown [69]. Used with permission.
A high signal-to-noise ratio in a spectrum indicates high levels of deuterated acyl
chains being incorporated into the lipids of the bacterial membrane. It is thus
useful to compare the intensity of the spectra. However, to compare the shape of
the spectra it is often clearer to compare spectra that have been normalized by
area. Hence, in this thesis, each 2H NMR spectrum is presented in its normalized
(spectra normalized by area) and unnormalized (absolute intensity spectra) form.
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2.3.2.1 Moment Analysis
One way to quantify the spectral shape and the changes to spectral shape caused
by AMPs is through moment calculation. In principle, the information contained
in the moments is sufficient to fully characterize a distribution function. The nth








where n are integer values. The first moment (n = 1) represents the mean of
the distribution and the second moment (n = 2) represents the mean square
of the distribution. Moments can also be calculated about some fixed point x0
for example the mean of the distribution, in which case they are named central







The second central moment, is perhaps the most important central moment be-
cause it represents the variance of the distribution [70].
The nth moment of a spectrum with a lineshape function (f(ω)) of the angular
frequency (ω) with respect to the Larmor angular frequency (ω0), ω − ω0 (for
simplicity called ω), is defined as [62, 68, 71]:






Due to the symmetry of the 2H NMR spectrum, all odd moments will tend to zero.
Redefining the limits of the moments calculation to avoid symmetry with respect
to the Larmor angular frequency, ω0, allows the use of the odd and even moments
[62, 68]. Redefined moments are then
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The purpose of calculating the moments of the 2H NMR spectra of bacteria is to
characterize the distribution of splittings. In the liquid crystalline phase, where
the C-D bonds are undergoing axial symmetrical movements, moments also char-
acterize the distribution of order parameters [68].
Because the quadrupolar splittings are much larger than the linewidth of the spec-
trum, the momentsMn (〈ωn〉) from f(ω) are proportional to 〈∆νnQ〉 and 〈SnCD〉, the
moments of the distribution of quadrupolar splitings, f(∆νQ), and the moments
of the order parameter distribution, f(SCD), respectively








The coefficients An are a result of the axially symmetric lineshape function of the
Pake doublet 2.14 [62] where, for example, A1 = (2/(3
√
3)) and A2 = (1/5). The
moments of the order parameter distribution (〈SnCD〉) and the moments of the
distribution of quadrupolar splittings (〈∆νnQ〉) can be defined using equation 2.18.
There is thus a proportionality between the means of the angular frequency with
respect to the Larmor frequency, quadrupolar splitting and order parameter dis-
tributions. The parameter ∆2 is defined as the relative mean square width of the





Notice that ∆2 is the second central moment or variance of the order parameter
distribution divided by the squared mean order parameter. ∆2 can also be defined









∆2 gives the relative mean square width of the distribution of quadrupolar split-
tings. In particular, ∆2 = 0 for a powder pattern spectrum of a vesicle with
a unique quadrupolar splitting value for each C-D bond, such as would be the
case for the spectrum shown in Figure 2.8. Larger values of ∆2 indicate wider
ranges of ∆νQ with respect to 〈∆νQ〉. In other words, changes in ∆2 values can
be interpreted as changes in membrane heterogeneity [71].
Moment analysis provides a useful characterization of spectral shape and thus of
the symmetry and amplitude of chain motions. Notice, however, that the strict
proportionality of the moments of the angular frequency distribution to the mo-
ments of the order parameters distribution is restricted to lipid bilayers in the
liquid crystalline phase when the 2H NMR spectrum is the superposition of pow-
der patterns with a zero asymmetry parameter η.
2.3.2.2 Kurtosis
The fourth central moment or kurtosis (∆4) is a measurement commonly used to
compare the weight of the tails and the peakedness of the distribution with the
normal distribution [72]. Since the changes induced in the 2H NMR spectra of
bacteria includes a change in the peakedness, it may be interesting to study the
possible changes in kurtosis generated by the AMPs in future studies. However,
it is possible that the noise of the spectra will interfere with the fourth moment
calculation, meaning that some testing might be needed before trying to use such
an approach.
2.4 Research Approach
The main goal of this project was to determine if the peptidoglycan layer, one
of the non-lipid components of the bacterial cell envelope, is relevant for under-
standing AMPs’ effects on the bacterial cell envelope. To do so, four objectives
were defined. The first objective was to characterize the 2H NMR spectrum of
B. subtilis, since this was the first time Gram + bacteria were probed with this
method, and to demonstrate reproducibility (Section 4.3). The second objective
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was to study the changes in the B. subtilis 2H NMR spectra in the presence of
different concentrations of MSI-78 and BP100 (Chapter 5). The third objective
was to explore possible changes in the B. subtilis 2H NMR spectra caused by the
partial or complete removal of the PGN layer (Section 6.1.1). Finally, the fourth
objective was to study the 2H NMR spectra of B. subtilis with a compromised
PGN layer in the presence of BP100 and MSI-78 (Section 6.2).
Chapter 3
Materials and Methods
Because the natural amount of deuterium present in lipids is not enough to per-
form 2H NMR experiments, our group and others have developed protocols to
introduce deuterated acyl chains into the cell envelope lipid bilayer of intact bac-
teria [1, 6–8]. There are different strategies to maximize the proportion of lipids
with deuteration in the membranes. The Pius et al.. [6, 7] protocol uses mutated
bacteria unable to metabolize and/or synthesize fatty acids. As a result of the mu-
tation, this bacteria needs fatty acids in the growth media to be viable and thus
membrane deuteration can be achieved by providing deuterated fatty acids in the
media. The Tardy-Laporte et al. protocol [1] employs non-mutated bacteria grown
in media supplemented with deuterated fatty acids complexed with detergent mi-
celles. Detergent micelles help to increase the uptake of acyl chains by the cells,
allowing them to be incorporated in the cell envelope lipid bilayer. In this project
both the Pius et al. protocol and a slightly modified version of Tardy-Laporte et
al. protocol [8] were used. For simplicity henceforth, our modified version of the
Tardy-Laporte et al. method will be referred to as "UB (Unmutated Bacteria)
method" and the Pius et al. as "MB (Mutated Bacteria) method".
This chapter includes the protocols to achieve a deuterium-rich membrane in three
bacterial strains, which require individualized growth conditions, as well as how
to treat bacteria with AMPs, partially remove the PNG layer in Bacillus subtilis,
perform Gram staining and extract lipids from bacteria. Additionally, the pro-
tocol to prepare multilamellar vesicles with perdeuterated lipids that were used
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in Figures 2.9 and 2.8 is described. Finally, the procedure to perform 2H NMR
measurements is also detailed.
3.1 Media Preparation
The media preparation protocols below have been previously published as part of
Santisteban et al. [8] .
3.1.1 Medium 63, LB broth and 2× YT
Medium 63, LB (Luria-Bertani) broth and 2× YT (2× amount of yeast extract
and 60% more tryptone than LB broth) were each prepared by dissolving the
appropriate components (See Table 3.1) into 800 mL of deionized water. Next,
the pH was adjusted to 7.0 (if needed) using NaOH and the volume was brought
up to 1 L with deionized water. 400 mL of the mixture (800 mL total) was placed
in each of two 4L flasks (one for each of two cultures). Each flask was closed
with a sponge plug and foil. The remaining volume of the mixture was placed
in a 500 mL media storage bottle. Finally, media were autoclaved and stored at
room temperature. The two-4L flasks were each used for one experiment and the
remaining volume was used for overnight cultures and for washing cells.
3.1.2 1× SMM Buffer
200 mL of 1× SMM buffer (sucrose, maleic acid and magnesium chloride), was
prepared dissolving all the components (See Table 3.1) into 200 mL of deionized
water. Next, using a 20 mL syringe, 20 mL of the mixture was passed through a
0.2 µm filter unit into each of ten 50 mL falcon tubes. Each falcon tube was used
for a lysozyme or AMP treatment. Ten 50 mL falcon tubes containing 20 mL of
1×SMM buffer each were stored at 4◦C.
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3.1.3 1× PBS Buffer
1 L of 1× phosphate buffered saline (PBS) buffer, was prepared by dissolving all
the components (See Table 3.1) into 1000 mL of deionized water. All the mixture
was placed in a 1 L media storage bottle. Finally, media was filtered using a 0.45
µm filter and stored at room temperature.
3.2 Labeling the Lipid Bilayer of the Bacterial En-
velope with Deuterated Acyl Chains
Bacterial strains and the 2H labeling methods used in this project are listed in
Table 3.2. All bacterial strains were stored at -80◦C in 1 mL aliquots. Each aliquot
contains 500 µL of glycerol and 500 µL of cells in growth media. All growth media
and buffer compositions are listed in Table 3.1. For NMR experiments with a final
pellet of ∼ 400 µL, it was necessary to grow 400 mL cultures.
3.2.1 Mutated Bacteria Method (MB Method)
A small culture of bacteria was grown overnight at 30◦C and used to inoculate a
larger culture grown during the day at 37◦C. Overnight cultures of E. coli LA8
were prepared in 50 mL falcon tubes by inoculating 9 mL of Medium 63-A (see
Table 3.2 and Section 4.1) with 1 mL aliquots of frozen glycerol cell stocks1.
Overnight cultures were placed in a 30◦C incubator with shaking speed of 150
rpm with a loosely fitting cap. The large-scale cultures were started with 1 mL
of overnight culture per 100 mL of fresh Medium 63-B (see Table 3.1) in a flask
at least 4 times bigger than the culture total volume. Each culture was protected
with a foam stopper and placed in an incubator at 37◦C with shaking speed of
175 rpm. Cells were finally harvested in midlog phase at an absorption at 600 nm
(A600) of 0.6 - 1.0. The cells were centrifuged at 4100 g for 10 minutes at 4◦C and
then transferred to a NMR tube (see more tube details in Section 3.8). 2H NMR
1Note that in this case, Media 63-A contains glycerol so, the final concentration of glycerol
of the overnight culture is ∼ 67 g/L
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Table 3.1: Media and buffers compositions.
Media/ Buffer Composition
Media 63
13.6 g/L KH2PO41 0.5 mg/L FeSO4.7H2O1
2 g/L (NH4)2SO41 4 g/L Glycerol2
0.2 g/L MgSO4.7H2O1
Media 63-A
13.6 g/L KH2PO4 4 g/L Glycerol
2 g/L (NH4)2SO4 1 mg/L Thiamine2
0.2 g/L MgSO4.7H2O 3 g/L Casamino acids
DifcoTM 1
0.5 mg/L FeSO4.7H2O 30 mg/L Kanamycin2
Media 63-B
13.6 g/L KH2PO4 3 g/L Casamino acids
2 g/L (NH4)2SO4 30 mg/L Kanamycin
0.2 g/L MgSO4.7H2O 1 g/L Brij-582
0.5 mg/L FeSO4.7H2O 50 mg/L Deuterated
palmitic acid (PA-d31)3
(0.174 mM)













2.321 g/L Maleic acid2
1.904 g/L MgCl22
1×PBS Buffer 8 g/L NaCl 1.44 g/L Na2HPO4
1
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Table 3.2: Summary of bacteria and 2H-labeling methods used.
Bacterial Strain Type 2H labeling Method
E. coli L8 (CGSC#5637) Gram - MB
E. coli JM109 (CGSC#8267) Gram - UB
Bacillus subtilis
(ATCC#E6051) Gram + UB
experiments were started no more than two hours after cell harvesting. Bacteria
with AMP treatment require additional steps that will be explained in Section 3.5.
3.2.2 Unmutated Bacteria Method (UB Method)
As explained above, UB method requires growing bacteria in media supplemented
with deuterated acyl chains complexed with detergent micelles. However, in the
case of E. coli JM109, the media were also supplemented with oleic acid (OA) com-
plexed with detergent micelles. UB method was used with two strains of bacteria:
E. coli JM109 and B. subtilis. Below is the protocol to form dodecylphospho-
choline (DPC) micelles complexed with hexadecanoic-d31, also known as palmitic
acid-d31 (PA-d31), or OA. Next, the particular protocol for each bacterial strain
will be explained.
3.2.2.1 PA-d31 and OA complexed with DPC micelles
A 10 mL solution containing the desired amount (specified below) of PA-d31 and
DPC sufficient to achieve the desired final concentration in the 400 mL culture
was prepared in a 50 mL falcon tube at room temperature with distilled water.
To ensure a correct concentration of PA-d31, the stock needed to be at room
temperature, i.e. the mixture should be clear with no precipitate. A second 10
mL mixture containing the desired amount (specified below) of OA and DPC
sufficient to achieve the desired final concentration in the 400 mL culture was
prepared in a 50 mL falcon tube at room temperature with distilled water. Next,
using a 0.2 µm syringe filter unit, each solution was filtered and transferred to a
second 50 mL falcon tube. Mixtures were subjected to at least 4 freeze-thaw cycles
by heating in a boiling water bath for at least 4 minutes and then submerging in
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liquid nitrogen until frozen solid. Finally, both tubes were warmed in a water
bath at room temperature until the edges of the ice melted. The whole 10 mL of
each mixture were added immediately to the growing media that was already in
the incubator at 37◦C and 175 rpm. Normally this is done within 30 minutes of
inoculation.
3.2.2.2 UB method using E. coli JM109
Overnight cultures of E. coli JM109 were prepared in a 50 mL falcon tube by
inoculating 9 mL of LB broth (see Table 3.1) with a 1 mL aliquot of frozen glycerol
cell stock. Overnight cultures were placed in a 30◦C incubator with a shaking speed
of 150 rpm with a loosely fitting cap. Next day, LB broth (see Table 3.1) at 37◦C
in a flask at least 4 times bigger than the culture total volume was supplemented
with 0.25 mM (final concentration) PA-d31 in 1 mM (final concentration) DPC,
and 0.25 mM (final concentration) OA in 1 mM (final concentration) DPC. The
large-scale cultures were started with 1 mL of overnight culture per 100 mL of
fresh supplemented LB broth and grown at 37◦C and 175 rpm. Each culture was
protected with a foam stopper. Cells were grown to midlog phase at an absorption
at 600 nm (A600) of 0.6 - 1.0. The cells were harvested by centrifugation at 4100
g for 10 minutes at 4◦C. Samples with AMP treatment require additional steps
that will be explained in Section 3.5. For samples with no AMP treatment, the
pellet resulting from the harvesting centrifugation was transferred into the NMR
tube (see more tube details in Section 3.8). 2H NMR experiments were started no
more than two hours after cell harvesting.
3.2.2.3 UB method using B. subtilis
Overnight cultures of B. subtilis were prepared in a 50 mL falcon tube by inocu-
lating 9 mL of 2×YT media (see Table 3.1) with a 1 mL aliquot of frozen glycerol
cell stock. Overnight cultures were placed in a 30◦C incubator with shaking speed
of 150 rpm with a loosely fitting cap. 2×YT media (see Table 3.1) at 37◦C in a
flask at least 4 times bigger than the culture total volume, was supplemented with
0.083 mM (final concentration) PA-d31 with 0.33 mM (final concentration) DPC.
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The large-scale cultures were started with 1 mL of overnight culture per 100 mL of
fresh 2×YT media with PA-d31/DPC and incubated at 37◦C and 175 rpm. Each
culture was protected with a foam stopper. Cells were harvested in midlog phase
at an absorption at 600 nm (A600) of 0.6 - 1.0. The cells were centrifuged at 5670
g for 20 minutes at 4◦C. Samples with lysozyme and/or AMP treatment require
additional steps that will be explained in Sections 3.3 and 3.5. For samples with
no additional treatment, the pellet resulting from the harvesting centrifugation
was placed in the NMR tube (see more tube details in Section 3.8). 2H NMR
experiments were started no more than two hours after cell harvesting.
3.3 Disrupting Peptidoglycan Layer with Lysozyme
Lysozyme from egg white was bought from Sigma-Aldrich. For a 400 mL culture,
the desired amount of lysozyme in the sample was dissolved in 20 mL of 1×SMM.
After the centrifugation to harvest the cells, the pellet was resuspended in 20
mL 1×SMM-lysozyme mixture and kept on ice for 10 minutes. Next, the cells
were centrifuged at 5670 g for 20 minutes at 4◦C. Samples with AMP treatment
require additional steps that will be explained in Section 3.5. For samples with
no additional treatment, the resulting pellet was transferred into the NMR tube
(see more tube details in Section 3.8). 2H NMR experiments were started no more
than two hours after cell harvesting.
3.4 Gram Staining and Microscopy
Gram staining was used as the to method confirm the change in the peptidoglycan
in the B. subtilis cell wall before and after the lysozyme treatment. The associa-
tion of the positively charged crystal violet molecules with the negatively charged
iodine molecules, forms large complexes that remain trapped in the peptidoglycan
layer of the Gram + bacteria after the decolorization process with ethanol. Since
the crystal violet is the reagent responsible for the purple color, Gram + bacteria
remain purple during the rest of the Gram staining process. On the contrary,
Gram - bacteria lose the crystal violet, along with the outer membrane. Thus, the
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counterstain, in this case safranin, enters into the now exposed thin peptidogly-
can layer giving a pink color to the bacteria. Gram’s crystal violet and Gram’s
safranin solutions were acquired from Sigma-Aldrich and Gram’s iodine solution
was prepared by mixing 1 g of iodine, 2 g of potassium iodine in 300 ml of distilled
water. A 1 mL aliquot of the bacterial sample was placed aside in a 1.5 mL micro
centrifuge tube before the final centrifugation as described in Section 3.3 or 3.5.
In a sterile environment, bacterial cells were placed and spread on a microscope
slide using a sterile cooled loop. Bacterial cells were heat fixed onto the micro-
scope slide by passing them several times through the flame of a burner until the
medium was completely evaporated. The slide was allowed to cool for at least
10 seconds. Next, crystal violet was gently transferred on the slide, smearing to
assure coverage, and let stand for 1 minute. Crystal violet was gently rinsed with
distilled water. Next, iodine solution was gently transferred on the slide and al-
lowed to stand for 1 minute. Iodine solution was gently rinsed with distilled water.
The fixed smear was decolorized using 95% ethanol for about 5 to 10 seconds or
until the ethanol ran almost clear. Ethanol was gently rinsed from the sample with
distilled water. Safranin was gently transferred on the slide, smearing to assure
coverage, and let stand for 45 seconds. Finally, safranin was gently rinsed with
distilled water. The slide was placed over towel paper and allowed to air dry for
about 5 minutes. Once the slide was completely dry, bacterial samples were ob-
served under a conventional light microscope using a 100x immersion oil lens. To
obtain an approximate scale bar, a 0.1 mm grid of a Motic microscope calibration
slide was placed under a conventional light microscope using a 100x immersion oil
lens. Pictures were taken using an iPhone SE and presented in section 6.1.
3.5 Treating Bacteria with AMPs
C-terminal amidated MSI-78 and BP100 peptides, were obtained from GenScript
and HPLC-purified to purity > 75%. All peptides were desalted via buffer ex-
change using SpectrumTM Spectra/PorTM dialysis membrane tubing (100-500 and
1000 Dalton MWCO). Samples were dialyzed against 95% purified water and 5%
acetic-acid for 24 hours and 100% purified water for at least another 24 hours.
The dialyzed sample was lyophilized and weighed. The amount of peptide for
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each sample was determined as a percentage of the bacterial dry weight. The
procedure to determine the bacteria dry weight using the absorption at 600 nm
(A600) will be explained first, followed by the protocol for treating bacteria with
AMP.
3.5.1 Determining the Bacteria Dry Weight
The amount of AMP in each sample was calculated as a percentage of the final
dry pellet mass. Because the amount of cells varies from sample to sample, a
relationship between the absorption at 600 nm (A600), just before the harvesting
centrifugation, and the bacteria dry weight is needed. To obtain this relationship,
a minimum of 5 cultures of bacteria enriched with palmitic acyl chains (Non-
deuterated palmitic acyl chains were used instead of PA-d31 in samples for experi-
ments that did not involve NMR measurements) were grown under the conditions
explained in Section 3.2.1 for E. coli LA8, Section 3.2.2.2 for E. coli JM109 and
Section 3.2.2.3 for B. subtilis. Cultures were harvested at different points of the
log phase (an absorption at 600 nm A600 = 0.6− 1.0) and pelleted using centrifu-
gation under the conditions as in 3.2.1, 3.2.2.2 and 3.2.2.3. Next, each pellet was
resuspended in 60 mL of growth media for 20 minutes with gentle shaking at room
temperature. The final pellets were placed with a clean spatula in pre-weighed
vessels and then placed in a vacuum chamber for 48 hours. After 48 hours each
vessel was reweighed. The bacterial dry weight is obtained by subtracting the
weight of the vessel from the weight of the vessel + dry bacteria.
As shown in Figure 3.1, an exponential relationship between the absorbance at 600
nm and the bacterial dry weight is expected. A linear fit of ln(dry weight) versus
the absorption at 600 nm (A600) gives the relationship equation that can be used
to calculate the bacterial dry weight and thus the appropriate amount of AMP to
add to the bacteria for NMR experiments. For example, if the absorbance of a B.
subtilis culture is 0.75, the dry weight of the pellet is 200 ± 60 mg2.
2Uncertainty calculations are displayed in Appendix A.2
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Figure 3.1: ln(Dry weight (mg)) cells vs absorbance at 600 nm (A600) for E.
coli (JM109) and B. subtilis. Linear regression were performed to obtain the
relationships shown in the graph.
3.5.2 AMP Treatment
Using the absorption at 600 nm (A600) just before harvesting, and the relationship
obtained in Section 3.5.1, the proper amount of AMP needed in the sample was
calculated. The peptide amount was weighed and dissolved in 60 mL of growth
media (medium 63 for LA8, LB broth for JM109 and 2×YT media for B. subtilis)
for the samples with no lysozyme treatment, or in 20 mL of 1×SMM buffer for
the lysozyme treated samples. The media or buffer + AMP mixture was used
to resuspend the pellet obtained after harvesting. The pellet was scraped from
the bottom of the centrifuge tube and gently vortexed to achieve a homogeneous
mixture. The centrifuge tube with the unattached pellet was then placed in an
orbital shaker at 200 rpm for 10 minutes at room temperature. Next, cells were
centrifuged at 4100 g (5670 g in the B. subtilis case), at 4◦C for 10 minutes (20
minutes in the B. subtilis case). The final pellet was transferred into the NMR
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tube (see more tube details in Section 3.8). 2H NMR experiments were started no
more than two hours after cell harvesting.
3.6 B. subtilis Lysate and Lipid Extraction
A 200 mL flask containing 69 mL of 2×YT media (see Table 3.1) was closed with
a sponge plug and foil and autoclaved. Once the flask with media reached room
temperature, overnight cultures of B. subtilis were prepared by inoculating the 69
mL of 2×YT media with 1 mL aliquots of frozen glycerol cell stocks. Overnight
cultures were placed in a 30◦C incubator with shaking speed of 150 rpm, protected
with a foam stopper. Six 4L flasks containing 1 L of 2×YT media (see Table 3.1)
each, were supplemented with 0.083 mM (final concentration) PA-d31 in 0.33 mM
(final concentration) DPC and pre-warmed to 37◦C. They were inoculated with 1
mL of overnight culture per 100 mL of fresh supplemented media and incubated
at 37◦C and 175 rpm. Each culture was protected with a foam stopper. Cells were
harvested in log phase at an absorption at 600 nm (A600) of 0.6 - 1.0. The cells
were centrifuged at 5670 g for 20 minutes at 4◦C. The resulting pellet was lysed
by three cycles of french press at a pressure of 10000 psi (6.9×107 Pa) and 4◦C to
generate cell lysate. The french press cycle consists of forcing the pellet through a
small valve at high pressure. The cells then experience shear stress that generates
cellular disruption resulting from the significant change in pressure. A cell lysate
volume of ∼ 30 mL was typical. 5 mL of the cell lysate was stored in a 15 mL
falcon tube at -20◦C for cell lysate experiments, and the remaining cell lysate was
used for lipid extraction.
A Bligh and Dyer method was implemented for lipid extraction [73] starting from
cell lysate. The initial volume (Vi) was measured using a graduated cylinder.
3.75×Vi of ice-cold chloroform/methanol (1:2) was mixed with the cell lysate to
generate a single phase mixture. The mixture was vortexed for 2 minutes and left
resting at room temperature for 5 minutes. 1.25×Vi of PBS (see Table 3.1) and
1.25×Vi of room temperature chloroform were added to the mixture to generate a
two-phase solution. The solution was vortexed for 5 minutes and then transferred
to a glass separation funnel. In order to obtain a clear lower phase, the solution
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was left resting at room temperature for approximately 2 hours. The lower phase
containing lipids suspended in chloroform/methanol was carefully recovered in a
beaker and dried under a N2 stream. The extracted lipids were placed under vac-
uum for 48 hours to ensure that any trace of chloroform/methanol was completely
removed.
Multilamellar vesicles (MLV) were prepared by adding 5 mL of 2×YT media to
the beaker containing the lipids and then vortexing the mixture until all the lipid
material was completely suspended. The sample was left to settle out for at least
one hour to allow MLV formation. The sample was kept at -20◦C until needed.
400 µL of the mixture was transferred to an NMR tube for each experiment.
3.7 Preparation of DPPC Multilamellar Vesicles
Using a 1.5 mL eppendorf centrifuge tube, 30 mg of DPPC was added to 400 µL
of PBS. The mixture was vortexed for 1 minute or until all the lipid material was
completely suspended. The mixture was then transferred to an NMR tube. The
sample was used immediately.
3.8 Performing NMR
2H NMR experiments were performed with an in-house-assembled 9.4 T solid-
state spectrometer. The NMR tube is a cylindrical tube with a round bottom
with external diameter of ∼ 8.2 mm and length of ∼ 25 mm. The NMR sam-
ple was inserted in a 10 mm diameter transverse sample coil on the NMR probe.
A Lakeshore Cryogenics Model 325 temperature controller was used to keep the
sample temperature at 37◦C. Probe tuning and matching were performed before
each experiment. A quadrupole echo pulse sequence ((π/2) − τ − (π/2) − acq)
with a 30 µs pulse separation (τ), a 5 µs pulse duration and a 900 ms recycling
delay, was used to acquire the time domain quadrupole echo signals. Each tran-
sient was acquired with a dwell time of 1 µs and 8192 points in each of the real
and imaginary channels. The dwell time needed to achieve a spectral width of
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250 kHz is 4 microseconds so this corresponds to oversampling by a factor of 4.
This allowed separation of the time domain signal into 4 subsequences that were
shifted and added to generate an echo with an effective dwell time of 4 µs and
a resulting improvement in the signal-to-noise ratio [74]. In order to monitor for
any change in spectral shape over time, transients were averaged in blocks of 8000
scans collected over 2 hours. Previous studies showed no major changes in spec-
tral shape over 8 hours of acquisition [6] which allowed the 32,000 transients to
be added together and processed. To minimize dispersive signal in the imaginary
channel, baseline correction and phase shift were applied to the quadrupole echo.
A Fourier transformation was applied to the free induction decay (FID), resulting
in the 2H NMR spectrum which was also baseline corrected and normalized by
area.
3.8.1 Quadrupolar echo
A typical 2H NMR spectrum of a lipid bilayer is acquired with a spectral width of
at least 250 kHz. This means that important information is contained in the early
part of the FID signal. At the same time, conventional spectrometers use the same
coil to excite the deuterium nuclei and to detect the FID signal, which typically
causes a dead time of about ∼ 20 µs and thus the potential loss of information in
the early part of the FID. In their 1976 paper, Davis et al. proposed the quadrupole
echo as an approach to avoid losing information in the early part of the FID due
to the dead time of the spectrometers [5]. The quadrupole echo pulse sequence
consists of two π/2 pulses separated by a time interval τ . The two pulses need to
be 90◦ out of phase and τ should be longer than the "dead time". This quadrupole
echo translates the t = 0 point of the FID beyond the "dead time" which prevents
the loss of crucial information.
Chapter 4
Spectra of 2H Labeled Bacteria
The first 2H NMR study of bacterial cell membranes using a quadrupole echo pulse
dates from 1975 when Stockton et al. studied the cell membrane extracted from
Acholeplasma Laidlawii, a small bacterium that lacks a cell wall [75]. In 1979,
Davis et al. published the first study of bacteria cell membranes of intact E. coli
cells [68]. This study was done on a specific strain of E. coli, L51, that was forced
to incorporate perdeuterated palmitic acid into the membrane bilayer due to its
defective fatty acid oxidation pathway. More recently, Pius et al. studied the effect
of the antimicrobial peptide MSI-78 in the cell membrane of LA8, a mutated strain
of E. coli [6]. Also, Tardy-Laporte et al. [1] studied the effect of antimicrobial
agents such as polymyxin, fullerenol and cetyltrimethylammonium chloride, in the
cell membrane of pPD117, an ampicillin resistant strain of E. coli.
4.1 Obtaining 2HNMR Spectra from E. coli(LA8)
One of the greatest challenges in this type of work is to demonstrate the repro-
ducibility of the NMR data obtained from the intact cells. Thus, a necessary
step was to perform multiple experiments with E. coli LA8 cells and compare the
results to each other and to previous work in our group.
As explained in section 3.2.1, the MB method for preparing bacteria with deuter-
ated membranes involves the use of bacteria with two specific mutations. One of
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the mutations stops acyl chain synthesis so that bacteria are not able to produce
acyl chains. The other mutation affects acyl chain metabolism. As a result, bacte-
ria are not able to use acyl chains as fuel. To create this double mutation, James
Pius started with L8 bacteria, a commercial strain of E. coli whose mutation
affects total acid synthesis, and introduced a secondary mutation that modifies
bacterial fatty acid metabolism [6]. The bacterial strain resulting from the two
mutations was named E. coli LA8. The inability to metabolize or synthesize acyl
chains restrains bacterial growth unless the growth media is supplemented with
acyl chains. Therefore, cultivating LA8 cells in growth media supplemented with
deuterated palmitic acid (PA-d31) and oleic acid (OA) results in bacterial cells
with deuterium-rich membranes.
Black spectra in Figure 4.1(a) show absolute intensity 2H NMR spectra of E. coli
LA8 and the red spectrum in Figure 4.1(a) shows absolute intensity 2H NMR
spectra of E. coli LA8 in the presence of 20% wt/wt MSI-78. The corresponding
spectra in Figures 4.1(b) and 4.1(c) are normalized by area. Spectra in black
correspond to six different preparations using the protocol in Section 3.2.1. Each
preparation was labeled with a different number starting from NS01 to NS08.
The five preparations giving the best signal-to-noise ratio are shown in Figure 4.1.
Preparations NS01 and NS05 in Figure 4.1(b) represent the highest signal-to-noise
ratio and preparations NS08 and NS09 the lowest. Preparations NS04, NS05 and
NS08 in Figure 4.1 display prominent edges at ∼ ±12.5 kHz. These prominent
edges result from the plateau region of the order parameter profile and indicate
multiple C-D bonds undergoing similarly constrained reorientations close to the
hydrophilic/hydrophobic interface of the bilayer. The quadrupolar splitting of the
prominent edges is ∼ 25 kHz. (SCD)plateau can be obtained using equation 2.15.
Applying this equation, the resulting (SCD)plateau value is ∼ 0.2 which, is consistent
with a liquid-crystalline phase bilayer. In summary, the resulting spectra are
characteristic of lipid bilayers in a liquid-crystalline state whose fatty acyl chains
undergo fast axially symmetric chain reorientation. Additionally, the prominent
edges correspond to the orientational order parameter plateau and the distribution
of smaller splittings correspond to the less ordered chain segments toward the
bilayer centre. Preparation NS05 was used as a reference to be compared with the
AMP treated sample on Figure 4.1(c) because it exhibits the best signal-to-noise
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Figure 4.1: 2H NMR spectra of E. coli (LA8) enriched with deuterated acyl
chains from six different preparations using the protocol in Section 3.2.1 showing
reproducibility of untreated cells in black and the effect of 20% MSI-78 (wt/wt)
in the spectrum in red. (a): Absolute intensity spectra in the absence (black)
and presence of AMP (red). (b): Spectra normalized by area in the absence of
AMP. (c): Spectra normalized by area in the absence of AMP (Black) and in the
presence of 20% MSI-78 (wt/wt) (red). Dashed lines at ±12.5 kHz are provided
to facilitate comparison of the spectra. All spectral intensities are represented
in arbitrary units (AU). Each spectrum represents 32,000 scans recorded over
eight hours at 37 ◦C in a 9.4 T NMR spectrometer.
ratio.
Figure 4.1(c) shows the comparison between the NS05 reference spectrum for E.
coli LA8 and the spectrum of E. coli LA8 in presence of 20% (wt/wt) MSI-78. A
slight reduction of the prominent edges at ∼ ±12.5 kHz was observed in the AMP
treated bacterial sample which may be due to the presence of the AMP, or just
the normal variability between samples. As shown next, it is likely the latter.
Table 4.1 shows the values of the first and second moments, M1 and M2, and the
relative mean square width of the order parameter distribution, ∆2, for all the
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Table 4.1: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR




NS01 4.34 3.46 0.36 untreated
NS02 4.43 3.45 0.31 untreated
NS04 3.98 2.85 0.33 untreated
NS05 4.52 3.79 0.37 untreated
NS08 4.58 3.77 0.33 untreated
Average over
untreated samples M1 ×10
4(s−1) M2×109(s−2) ∆2
4.4 ± 0.2 3.5 ± 0.3 0.34± 0.03
NS09 4.31 3.40 0.35 20%(wt/wt)MSI-78
spectra shown in Figure 4.1. The values for five untreated samples were averaged
and standard deviations calculated to help illustrate the variability between dif-
ferent samples using the same bacterial strain and protocol. It is fair to say that
the AMP-treated samples would display a similar variability. The uncertainties
in the averages reported in Table 4.1 are the standard deviations. The M1, M2,
and ∆2 values were similar, but not identical to those obtained by Pius et al. [6]
and will be discussed below in section 4.5. Additionally, Table 4.1 shows that the
addition of 20% MSI-78 did not induce significant changes to the moments or ∆2
values with respect to the average over the untreated samples.
In summary, these results demonstrated that deuterated fatty acyl chains could
be successfully introduced into the membrane of E. coli LA8 and reproducible
spectra can be obtained. Cell viability is expected to be similar or better than that
observed by Pius at al. [6] because there was no washing step before performing
the NMR measurement. In this series of experiments, no AMP-induced change
was observed to result from the addition of 20% MSI-78.
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Table 4.2: Fatty acid composition of the membranes of unlabeled and labeled
E. coli using the protocol explained in Tardy-Laporte paper in 2013. Data
obtained from [1].








(C16:0) (C16:0D) (C16:1) (C17:1) (C18:1)
Labeled 7 76 9 1 7
Unlabeled 36 0 28 3 33
4.2 Obtaining 2HNMR Spectra from E. coli JM109
In 2013 Tardy-Laporte et al. published an alternate method for growing deuterated-
membrane-rich E. coli pPD117 [1]. This method offers the benefit of being appli-
cable to non-mutated type bacteria instead of mutated strains. The next group of
experiments was aimed at obtaining consistent 2H NMR spectra of E. coli JM109.
In this set of experiments, the main difference between our protocol and the proto-
col described by Tardy-Laporte et al. is the addition of oleic acid, complexed into
DPC micelles, to the growth media in our protocol. The Tardy-Laporte protocol
leads to a relatively high percentage of cell death compared with the Pius et al.
protocol [6] which uses bacterial growth medium containing both palmitic acid
and oleic acid. I hypothesized that the relatively high percentage of cell death
is related to the absence of oleic acid in the growth medium when these bacte-
ria typically have a significant amount of oleic acid (See Table 4.2) [1]. Thus, it
was decided to incorporate oleic acid into the growth media to improve bacterial
viability.
The black spectra in Figure 4.2(a) show the absolute intensity 2H NMR spectra
of E. coli JM109 and the red spectrum in Figure 4.2(a) shows absolute intensity
2H NMR spectrum of E. coli JM109 in the presence of 17% (wt/wt) MSI-78. The
corresponding spectra in Figure 4.2 (b) and (c) are normalized by area. Spec-
tra in black correspond to two different preparations using the protocol detailed
in Section 3.2.2.2. Both preparations (NS11 & NS12) exhibit similar values of
raw intensity, i.e. similar values of signal-to-noise ratio. 2H NMR spectra of un-
treated E. coli JM109 in Figure 4.2 display prominent edges at ∼ ± 12.5 kHz
with quadrupolar splittings of ∼ 25 kHz. As for E. coli LA8, these prominent
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Figure 4.2: 2H NMR spectra of E. coli JM109 enriched with deuterated acyl
chains from two different preparations in black using the protocol in Section
3.2.1 (showing reproducibility) and the effect of 17% MSI-78 (wt/wt) in the
spectrum, in red. (a): Absolute intensity spectra in the absence and presence
of AMP. (b): Spectra normalized by area in the absence of AMP. (c): Spectra
normalized by area in the absence of AMP (black) and in the presence of 17%
MSI-78 (wt/wt) (red). Dashed lines at ±12.5 and ±62.5kHz are included to
facilitate comparison of the spectra. All spectra intensities are represented in
arbitrary units (AU). Each spectrum represents 32,000 scans recorded over eight
hours at 37 ◦C in a 9.4 T NMR spectrometer.
edges are a result of the plateau region of the order parameter profile and indicate
multiple C-D bonds undergoing similarly constrained reorientations close to the
hydrophilic/hydrophobic interface of the bilayer. Additionally, there is intensity
out to frequencies of ∼ ± 62.5 kHz. Such large splittings point to the presence of
a highly ordered structure and indicate that the deuterated acyl chains are em-
bedded in a structure where their movements are more restricted, i.e. not in the
liquid-crystalline phase. The possible nature of this structure is discussed below.
Preparation NS12 was used as a reference to be compared with the AMP treated
sample in Figure 4.2(c) because it exhibits the best signal-to-noise ratio.
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Figure 4.2(c) shows the comparison between a reference spectrum of E. coli JM109
and the spectrum of E. coli JM109 in the presence of 17% (wt/wt) MSI-78. A
significant reduction of the prominent edges at ∼ ± 12.5 kHz and an increase in
the intensity at narrower splittings was observed for the AMP treated sample.
Table 4.3: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR




NS11 8.5 14.9 0.517 untreated
NS12 10.1 19.5 0.414 untreated
Average over
untreated samples M1 ×10
4(s−1) M2×109(s−2) ∆2
9± 1 17 ± 3 0.47± 0.07
NS13 8.2 15.4 0.680 17%(wt/wt)MSI-78
Table 4.3 shows the calculated values of the first and second moments,M1 andM2,
from the spectra, along with the ∆2 values, for all the spectra shown in Figure 4.2.
The moment values (M1 and M2) and ∆2 of two untreated samples were averaged
and standard deviation calculated to help assess the variability between different
samples using the same bacteria strain and protocol. The average of M1, M2 and
∆2 were used to compare with previous reported values and the AMP treated
sample presented here. The uncertainties in the averages reported in Table 4.3 are
standard deviations. The M1, M2 values differ from the ones reported by Tardy-
Laporte et al. [1] and will be discussed in section 4.5. Additionally, Table 4.3
shows that the addition of 17% MSI-78 does not change the M1 and M2 values
within the uncertainty, however, there is an increase in the ∆2 value. It appears
that ∆2 is more sensitive to the AMP-induced spectral changes.
4.3 Obtaining 2H NMR Spectra from B. subtilis
Once the protocol using DPC complexes was successfully implemented in Gram -
E. coli, a decision was made to translate the AMP studies to Gram + bacteria.
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The change was performed because Gram + bacteria have a thicker peptidoglycan
layer than Gram - bacteria and only a single membrane bilayer (See Section 2.1).
A first attempt to obtain membrane-deuterated B. subtilis using the same pro-
tocol as with E. coli JM109 failed because the bacterial growth time increased
substantially. The increase in growth time was likely due to the bacteria strug-
gling to thrive in the presence of acyl chains complexed with detergent micelles.
The concentration of the DPC+PA-d31 complexes was optimized to decrease the
growth time and to maximize the amount of deuterated acyl chains on the sample.
Additionally, since the amount of oleic acid in the membrane lipids of B. subtilis
is small, oleic acid + DPC complexes were removed from the B. subtilis growth
media.
The black spectra in Figure 4.3(a) show absolute intensity 2H NMR spectra of B.
subtilis and the corresponding spectra in Figure 4.3(b) shows the spectra normal-
ized by area. Spectra of six different preparations using the protocol detailed in
Section 3.2.2.3 are shown. All preparations except for NS43 exhibit similar values
of signal-to-noise ratio. 2H NMR spectra of B. subtilis in Figure 4.3 display promi-
nent edges at ∼ ± 12.5 kHz. These prominent edges result from the plateau region
of the order parameter profile. A low intensity spectral component between ∼ ±
62.5 kHz is present in all the 2H NMR spectra of B. subtilis and will be discussed
below.
Table 4.4: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR




NS39 5.9 7 0.52 untreated
NS40 5.3 6 0.46 untreated
NS43 5.3 6 0.69 untreated
NS44 6.5 9 0.62 untreated
NS53 7.9 13 0.60 untreated






6 ± 1 8± 3 0.59± 0.08
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Figure 4.3: 2H NMR spectra of B. subtilis enriched with deuterated acyl chains
from six different preparations using the protocol in Section 3.2.2.3 showing re-
producibility of spectra obtained from untreated cells. (a): Absolute intensity
spectra. (b): Spectra normalized by area. Dashed lines at ± 12.5 kHz are in-
cluded to facilitate comparison of the spectra. Each spectrum represents 32,000
scans recorded over eight hours at 37 ◦C in a 9.4 T NMR spectrometer.
Table 4.4 shows the calculated values of the first and second moments, M1 and
M2, along with the ∆2 values for all the spectra shown in Figure 4.3. The mo-
ment values (M1 and M2) and ∆2 of six untreated samples were averaged and
the standard deviation was reported to indicate the variability between different
samples. A substantial variation in theM2 value between the samples is observed.
This variation likely reflects differences in the intensity of the high order spectral
feature. Preparation NS53 was used as a reference spectrum for assessing AMP
effects because it exhibits the best signal-to-noise ratio. However, becauseM1 and
M2 values of NS53 are larger than those obtained from similarly prepared samples,
the averaged values of M1, M2 and ∆2 were used as a reference for comparison to
data discussed in Section 4.5.1, Chapter 5 and 6.
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4.4 Highly Ordered Structure in the 2HNMR Spec-
tra of E. coli JM109 and B. subtilis
Despite the fact that the MSI-78 did not show any effect on the higher order com-
ponent in the 2H NMR spectra of E. coli JM109 and B subtilis (presented below),
I was curious to explore the nature of this highly ordered structure. The appear-
ance of spectral intensity between ∼ ± 62.5 kHz in the 2H NMR spectra of E.
coli JM109 and B. subtilis suggests the presence of a fatty acid structure or mem-
brane structure in a gel-like phase. Quadrupolar splittings near 125 kHz indicate
that most of the chain is exclusively undergoing reorientations about its long axis.
It is clear that spectral intensity corresponding to this highly ordered structure
appeared only in the 2H NMR spectra of unmutated bacteria prepared using the
protocol described in Section 3.2.2 that employs PA-d31 + DPC mixtures in the
growth media. So, the first possible explanation was that the sample contained
some PA-d31 + DPC that was not taken up by the cells and that possibly was
forming a gel phase-like fatty-acid-structure. In order to test this possible expla-
nation, the 2H NMR spectra of 2 mM DPC + 0.5 mM PA (the concentration of
the DPC+PA mixture was doubled to ensure there was enough deuterium in the
sample) at 37◦C was obtained (see Figure 4.4). The 2H NMR spectrum of PA-d31
+ DPC mixture (black in Figure 4.4) shows a spectral doublet, characteristic of
axially symmetric reorientation, with sharp edges at ∼ ± 16 kHz and a narrow
central peak characteristic of isotropic reorientation. There is, however, little in-
tensity at higher splittings. This implies that the PA-d31 + DPC mixture does
not form a highly ordered structure in the absence of cells. Hence, residual PA-
d31 + DPC in the sample is not responsible for observation of the highly ordered
structure in the 2H NMR spectra of E. coli JM109 or B. subtilis.
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Figure 4.4: Comparison of the 2H NMR spectra of the mixture 2 mM DPC
+ 0.5 mM PA-d31 at 37◦C (black), DPPC-d62 at 20◦C (red) and E. coli JM109
(NS12) enriched with deuterated acyl chains at 37◦C (blue). Dashed lines at ±
16 and ± 62.5 kHz are included to facilitate comparison of the spectra. Each
spectrum represents 32,000 scans recorded over eight hours in a 9.4 T NMR
spectrometer.
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Figure 4.5: 2H NMR spectra of 30 mg of DPPC-d62 dissolved in 2×YT media
at 42◦C (black), 35◦C (red) and 20 ◦C (blue). Dashed lines at ±16 and ±62.5kHz
are included to facilitate comparison of the spectra. Each spectrum represents
32,000 scans recorded over eight hours in a 9.4 T NMR spectrometer.
Whatever the intensity between ∼ ± 62.5 kHz is, it must derive from highly
ordered lipid or fatty acid. For example, it would be expected for DPPC-d62 in gel
state (below 37◦C1) or for mixtures of perdeuterated palmitate and water in the
gel phase at 38◦C [71]. Figure 4.5 shows how the spectrum of DPPC-d62 changes
from the liquid crystalline phase at 42◦C to the gel phase at lower temperatures.
In the gel phase, the acyl chains are ordered and reorientation about the chain axis
is too slow to be axially symmetric on the NMR timescale. For splittings close to
± 62.5 kHz, the shape of the DPPC-d62 gel phase spectrum (20◦C) is similar to
the spectral component seen at similar splittings in the spectra of E. coli JM109
and B. subtilis at 37◦C. This suggests that the broad spectral component seen for
these samples arises from slow reorientation of highly ordered acyl chains. It thus
1Note that the transition temperature of DPPC-d62 is around 5◦C below the transition tem-
perature of DPPC.
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seems plausible that the bacteria are retaining and storing lipids in a non cell-
membrane site in a gel-like phase state or that gel-like domains are being formed
in the bacterial membrane.
Bacteria are known for being able to store nutrients and even proteins [76, 77].
Also, the formation of lipid domains has been suggested in B. subtilis and E. coli
membranes [78, 79]. So, given the excess of acyl chains in the growing media,
unmutated bacteria could be producing lipids with high bilayer transition tem-
peratures and either storing them or placing them into the bacterial membrane.
Determining the phospholipids that each bacteria might be producing would re-
quire a complete study of the bacterial phospholipid composition of E. coli JM109
and B. subtilis grown using the UB method described in Section 3.2.2. Nonethe-
less, some clues can be obtained from an analysis of previous studies.
In 2013, Tardy Laporte et al. reported the change of the fatty acid composition
of E. coli pPD117 induced by the presence of DPC+PA-d31 in the growth media
[1]. Their findings were summarized in Table 4.2. It is clear that E. coli pPD117
considerably modified its fatty acid composition in response to the acyl chains
available in the growth media. Thus, it is reasonable to suppose that the presence
of DPC+PA-d31 (and DPC+OA for E. coli JM109) in the growth media could
lead to the presence of phospholipids whose acyl chain components are deuter-
ated palmitic acid, 16-carbon chains, (and oleic acid, 18-carbon chains, with a cis
unsaturation on the ninth carbon) in the case of E. coli JM109). Phospholipids
with one saturated acyl chains, such as palmitic acid, have higher transition tem-
peratures than the ones with acyl chains with one unsaturation, regardless of the
phospholipid head group [80]. However, the phase state of phospholipids also de-
pends on the phospholipid headgroup. As mentioned in section 2.1.1, phospholipid
composition changes depending on the environmental conditions, growth phases
and bacterial strains [10] however, previous lipidomics studies performed in E. coli
reported the presence of primary phosphatidylethanolamine (PE), phosphatidyl-
glycerol (PG) [81? ] and, cardiolipin (CL) [82]. With this in mind, it may be that
unmutated E. coli and B. subtilis grown using the UB method (described in Sec-
tion 3.2.2) produce significant amounts of DPPE as well as cardiolipin with more
than one deuterated palmitic acid chain. The transition temperature between the
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liquid crystalline and gel phase of DPPE is 63◦C. For cardiolipin with four palmitic
acids, the transition temperature is 62.2◦C. So, if E. coli JM109 and B. subtilis are
producing DPPE or cardiolipin with more than one 16-carbon acyl chain, those
lipid aggregates (lipid domains or lipid aggregates inside the cell) would be in
the gel-phase state, at 37◦C (25◦C below their transition temperatures). This is
consistent with the observation that the ordered phase in the 2H NMR spectra
from E. coli JM109 is similar to that observed in the spectrum of DPPC-d62 at
20◦C (17◦C below its transition temperature) shown in Figure 4.5. The lack of
this highly order structure in the spectra of the mutated E. coli LA8 suggests that
the PA-d31 is possibly not incorporated in as large a range of lipids as in E. coli
JM109 and B. subtilis.
4.5 Discussion
This chapter describes the 2H NMR spectra of deuterated lipids in E. coli LA8,
E. coli JM109 and B. subtilis. All the spectra exhibit characteristics that indicate
the presence of a lipid liquid-crystalline phase, despite the differences in lipid
composition and bacterial envelope composition between the organisms. All the
bacteria preparation protocols resulted in reproducible spectra (Figures 4.1, 4.2
and 4.3).
In order to compare the results obtained here for E. coli LA8 with previous studies,
the values of M1, M2 and ∆2 for untreated samples from Table 4.1 were compared
with the values reported by Pius et al. in 2012 [6]. The values reported by Pius et
al. ranged from 4.5 ×104 s−1 to 4.9 ×104 s−1 forM1, from 3.4 ×109 s−2 to 4.1 ×109
s−2 for M2, and from 0.27 to 0.28 for ∆2. Thus, the M1 and M2 values obtained
here are between the Pius et al. M1 and M2 values. ∆2 is a measure of the overall
shape in the spectrum, i.e. the distribution of splittings (see Section 2.3.2.1) and is
also inversely proportional to M1. As a consequence, the slightly lower M1 values
observed in the spectra reported here are expected to lead to the slightly higher
values of ∆2. While there may be some minor differences in bacterial preparation
protocols that lead to slightly different ∆2 values, the most important result is
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that within the dataset reported here, the spectra and moments calculated from
the spectra are consistent.
The results obtained for E. coli JM109 were also compared with previous results
in ampicilin resistant E. coli pPD117. The values of M1, M2 and ∆2 from Table
4.3 were compared with the values of M1, M2 and ∆2 reported by Tardy-Laporte
et al. in 2013 [1]. The values reported by Tardy-Laporte et al. are 6.3 ×104 s−1
for M1, 9.0 ×109 s−2 for M2 and 0.68 for ∆2. The average M1 and M2 values in
this study are 48% and 98 % larger (respectively) than those in Tardy-Laporte et
al. while the ∆2 value reported value here is 30% smaller. The main difference
between the spectra reported in Figure 4.2 and the one reported by Tardy-Laporte
et al. is the presence of intensity out to frequencies of ∼ ± 62.5 kHz, also referred
to in this thesis as the "highly ordered structure". This feature is responsible
for the larger M1 and M2 values reported here. Overall, the M1 and M2 values
reported here indicate that the proportion of lipids in a gel-like phase is greater
for the deuterated bacteria relative to those reported by Tardy-Laporte et al.
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4.5.1 Comparison of the E. coli (LA8), E. coli JM109 and
Bacillus subtilis 2H NMR Specta
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Figure 4.6: Comparison of the 2H NMR spectum of E. coli JM109, E. coli
(LA8) and B. subtilis enriched with deuterated acyl chains. (a): Absolute in-
tensity spectra. (b): Spectra normalized by area. Dashed lines at ±12.5 and
±62.5 kHz are included to facilitate comparison of the spectra. Each spectrum
represents 32,000 scans recorded over eight hours at 37 ◦C in a 9.4 T NMR
spectrometer.
As mentioned above, the bacterial cell envelope has several functions but each
species of bacteria accomplishes the same objectives in different ways. In partic-
ular, even though the lipid bilayer of the bacterial cell envelope is an essential
component for all bacteria, each bacteria species has a distinctive lipid composi-
tion [10]. Due to the differences in bacterial cell envelope and lipid composition
between E. coli LA8, E. coli JM109 and B. subtilis they might not necessarily be
expected to give the same 2H NMR spectra.
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Table 4.5: Comparison of the deuterated acyl chains provided in the media for
growing E. coli (LA8), E. coli (JM109) and Bacillus subtilis.
Bacterial species PA-d31 concentration([PA-d31]) (mM)
Raw intensity at
+ 12.5 kHz (AU)
Raw intensity
ratio to [PA-d31]
E. coli LA8 0.174 3.5 ± 0.7 20 ± 4
E. coli JM109 0.25 10 ± 2 39 ± 7
B. subtilis 0.083 4.2 ± 0.9 51 ± 10
The 2H NMR spectra of E. coli (LA8), E. coli JM109 and B. subtilis are shown
together in Figure 4.6. Figure 4.6(a) shows absolute intensity 2H NMR spectra
and Figure 4.6(b) shows the corresponding 2H NMR spectra normalized by area.
One of the more evident differences between the three 2H NMR spectra shown
in Figure 4.6 is the difference in the raw intensity (Figure 4.6(a)). Considering
that the mass of cells loaded into the NMR tube is very similar (See the relation
between the ln(Dry weight) and A600 for E. coli JM109 and B. subtilis in Figure
3.1), the differences in the raw spectral intensity are likely due to the amount of
deuterated acyl chains incorporated into the bacterial cell envelopes.
Another comparison of interest is the relative amount of uptake of deuterated acyl
chains by the three types of bacteria. Henceforth, the concentrations of deuterated
palmitic acid ([PA-d31]) in the growing media will be referred as PA-d31 concen-
tration. Thus, the raw intensity to PA-d31 concentration ratio can be considered
as an indicator of the acyl chain uptake of each strain. As explained above, the
concentration of deuterated acyl chains in the growth media is different for each
species of bacteria depending on the membrane-deuteration strategy and on the
lipid membrane composition of each species (See Section 3.2). The raw intensity
to PA-d31 concentration ratio was calculated for each spectrum shown in Figures
4.1, 4.2, 4.3 and tabulated in Table 4.5, along with the PA-d31 concentration and
the average over all raw intensity samples at + 12.5 kHz and the standard devia-
tion was reported as the uncertainty. Notice that E. coli LA8 has the lowest raw
intensity to PA-d31 concentration ratio and B. subtilis the largest. It appears that
B. subtilis achieves a more efficient PA-d31 uptake and that E. coli LA8 shows the
lowest uptake. Comparison of the ratio of E. coli LA8 and JM109 strains indicates
that using DPC + fatty acids in growth media results in more 2H incorporation
into the membrane than using the mutated E. coli.
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Figure 4.6(b) shows that all bacterial spectra share sharp edges at ∼ ± 12.5 kHz.
This is an indicator that the bacterial membranes of the three bacteria are in the
liquid-crystalline state.
4.5.2 2H NMR spectra of whole bacteria in the presence of
AMPs
The small changes observed in the spectral shape of E. coli LA8 (Figure 4.1) and
in the M1, M2 and ∆2 values of the AMP-treated bacterial sample (Table 4.1) are
likely within the normal variability between samples. It may be that 20% wt/wt
AMP is not enough peptide to see a substantial change in the spectral shape, at
least for these bacteria. Because the production of large AMP quantities was an
obstacle at the time this work was done, it was decided to use the AMP available
for future experiments.
Unlike the case for E. coli LA8, treatment of E. coli JM109 with 17% wt/wt
MSI-78 (Figure 4.2) induced changes in the ∆2 values (Table 4.3). The increase
in the mean square width of the order parameter distribution, ∆2, presumably
reflects the increase in intensity close to the methyl deuteron doublet and the re-
duction of the sharp edges that occurs only in the presence of the AMP. Those
changes indicate a change of the order parameter profile that is reflected in ∆2. A
reduction of the quadrupolar splitting in the plateau region of the order param-
eter profile is commonly reported in the 2H NMR studies of model lipid systems
when they are treated with different AMPs [48, 83–88]. The transfer, however,
of intensity from the prominent edges region to narrower splittings as a result of
AMP treatment is, to the best of our knowledge, only seen in the 2H NMR spectra
of deuterated-rich-membrane of whole bacterial cells [6, 8]. It is interesting to
consider the types of changes in lipid order and/or structure that are consistent
with the changes in the shapes of the NMR spectra with AMPs. On the one hand,
highly curved structures like hexagonal phases or lipid pores give rise to increases
in the intensity at the narrower splittings along with smaller quadrupolar splittings
than the ones observed in a lipid bilayer in a liquid-crystalline phase. In effect,
the order parameter profiles of highly curved lipid structures tend to present a
less pronounced plateau region and show a more linear decay of order along the
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chain. The generation of toroidal pores by AMPs has been suggested in previous
NMR studies, including Marcotte et al. in 2003 [89], Bertelsen et al. in 2012 [90]
and, Kwon et al. in 2013 [91], and it is possible that perturbation of bilayers in
this way might result in an order parameter profile consistent with the spectral
changes seen in Figure 4.2. On the other hand, in model lipid bilayers treated with
AMP, there is a decrease in the order parameter in the plateau region without the
increase of intensity at narrow splittings. This has generally been interpreted as
AMP-induced-disordering of the head group region.
A preferential interaction of certain AMPs with specific lipid domains [92, 93] led to
the proposal of an additional mechanism of AMPs that involves the modification of
lipid domains [78, 94, 95]. Lipid domains can be described as membrane areas with
different lipid composition. The existence of those domains in bacterial membranes
has been discussed at length [78, 96–99]. To explore the possibility that lipid
domains underlie either the highly ordered components of the spectra, or relate to
the AMP-induced changes observed in later chapters, it is important to consider
the size of the domains and if they are likely to be observable on the timescale of
these NMR experiments.
4.5.3 Can lipid domains be measured during the timescale
of a 2H NMR measurement?
The formation of domains has been suggested to depend on lipid charge and in-
trinsic curvature, and has been related to the distribution of cardiolipin and mem-
brane proteins in the bacterial membrane [99]. Mukhopadhyay et al. proposed a
theoretical model that suggests that lipids with a certain intrinsic curvature can
aggregate and form lipid domains [100]. Because of the intrinsic curvature of those
lipids side by side, the size of a lipid domain can be defined with a curvature ratio.
Mukhopadhyay et al. predicted an optimal domain size of γ= 10 −1 nm which is
an area of approximately 31.4× 103 Å or ∼ 500 lipids with a polar head area of ∼
64 Å2 each [100]. In order to be able to observe a two-component 2H NMR spec-
trum, the fraction of lipids exchanging between environments on the timescale of
the NMR observation must be small. The minimum domain size for which distinct
spectral components could be observed can be estimated by considering a single
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fluid lipid bilayer, where the lipids are free to diffuse with a diffusion constant D
∼ 10 µm2/s [100], and an experimental timescale of τ . 10−5 s [62]. During the
time of an NMR observation, a labeled lipid is able to sample an area of A ∼
π〈r〉2 = 4πDτ= 125.7 × 103 Å2. Thus, during a 2H NMR measurement, a labeled
lipid is able to sample an area approximately four times bigger than the predicted
size of a bacterial membrane lipid domain. The resulting spectrum would be ex-
pected to reflect a two-weighted average lipid environment. This comparison also
suggests that the source of the ordered phase components observed in the E. coli
JM109 and B. subtilis spectra is unlikely to be ordered phase domains within the
bacterial membranes. Thus, the existence of small lipid domains is possible but it
is unlikely to be directly detectable during a 2H NMR measurement.
Chapter 5
B. subtilis Interaction with AMPs
The main goal of this project is to determine if the peptidoglycan layer in the bac-
terial cell envelope impacts the interaction between the bacterial lipid membrane
and two different AMPs, MSI-78 and BP100. Section 4.3 described the charac-
terization of the 2H NMR spectra of B. subtilis, which was the first step toward
achieving the main goal. The next step was to study the changes in B. subtilis
2H NMR spectra in the presence of MSI-78 and BP100. To do so, the 2H NMR
spectra of B. subtilis treated with each peptide at different concentrations were
obtained and compared with the control spectra.
5.1 Changes in the 2H NMR spectra of deuterium-
enriched B. subtilis induced by MSI-78
Figure 5.1(a) shows the absolute intensity 2H NMR spectra and Figure 5.1(b) the
spectra normalized by area of B. subtilis in absence of MSI-78 in black, in the
presence of 10% wt/wt of MSI-78 in blue and in the presence of 20% wt/wt of
MSI-78 in pink. Comparison of the reference spectrum and the spectra of MSI-78-
treated samples in Figure 5.1(b) shows a significant change in the spectral shape
with the addition of the peptide. The changes in the spectral shape resulting from
the interaction with the AMP included a reduction of the prominent edges at ∼
± 12.5 kHz and an increase of the intensity at narrower splittings. Changes in
65
B. subtilis Interaction with AMPs 66





















































Figure 5.1: Change in 2H NMR spectra of B. subtilis induced by the presence
of MSI-78. Black: reference spectrum (NS53) with no peptide; Blue: with 10%
MSI-78 (wt/wt); Magenta: with 20% MSI-78 (wt/wt). (a): Absolute Intensity
spectra. (b): Spectra normalized by area. Samples were prepared using the
protocol explained in Sections 3.2.2.3 and 3.5. Dashed lines at ±12.5 kHz are
shown to facilitate comparison of the spectra. Each spectrum represents 32,000
scans recorded over eight hours at 37◦C in a 9.4 T NMR spectrometer.
the spectral shape are slightly more pronounced for the sample treated with 20%
wt/wt MSI-78 than for the sample treated with 10% wt/wt MSI-78. The changes
in the spectral shape are consistent with a reduction in the average orientational
order of the acyl chains in the membrane.
Table 5.1 shows the comparison of the M1, M2, and ∆2 values for the 2H NMR
spectra of B. subtilis in the absence and presence of MSI-78. While the shape
of the spectra with 10 and 20% MSI-78 appear substantially different from the
reference spectrum and all the control spectra shown in Figure 4.3, the changes
in M1 and M2 resulting from treatment with 10% MSI-78 are not different within
the estimated uncertainty. However, ∆2 provides a better reflection of the spectral
shape changes and increases noticeably as AMP concentration increases. In fact,
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Table 5.1: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectra of B. subtilis in the absence of AMP (average over six samples shown in





M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
untreated samples) 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
10 6.1 9.5 0.92
20 4.4 6.5 1.45
after treatment with 20% MSI-78, ∆2 more than doubled relative to its value for
the untreated sample.
5.2 Changes on the 2HNMR spectra of deuterium-
enriched B. subtilis induced by BP100
Figure 5.2(a) shows the absolute intensity 2H NMR spectra and Figure 5.2(b) the
spectra normalized by area of B. subtilis in the absence of BP100, in black, and in
the presence of 20% wt/wt BP100, in red. The comparison between the reference
spectrum (black) and the BP100 treated sample (red) shows a significant change
in the spectral shape. As with 20% wt/wt MSI-78, the presence of 20% wt/wt
BP100 causes a reduction of the prominent edges at ∼ ± 12.5 kHz and an increase
of the intensity at smaller splittings. Only one concentration of BP100 was tested
due the similarity of the effect of 20% wt/wt MSI-78 with the effect of 20% wt/wt
BP100. The changes in the spectral shape are consistent with a decrease in the
average orientational order of the acyl chains in the membrane.
Table 5.2 shows the comparison of the M1, M2, and ∆2 values for the 2H NMR
spectrum of B. subtilis in the absence and presence of BP100. The observed
decrease in M1 value upon the addition of BP100 indicates a shift of the splittings
to smaller values. There is also a decrease in the M2 values upon the addition of
20% BP100 and a considerable increase in the ∆2 values upon the addition of 20%
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Figure 5.2: Change in 2H NMR spectra of B. subtilis induced by the presence
of BP100. Black: reference spectrum (NS53) with no peptide; Red: with 20%
BP100 (wt/wt). (a): Absolute Intensity spectra. (b): Spectra normalized by
area. Samples were prepared using the protocol explained in Sections 3.2.2.3
and 3.5. Dashed lines at ±12.5 kHz are shown to facilitate comparison of the
spectra. Each spectrum represents 32,000 scans recorded over eight hours at
37◦C in a 9.4 T NMR spectrometer.
BP100. This behavior indicates that the distribution of quadrupolar splittings is
getting broader, despite the decrease in the average splitting.
5.3 Discussion
This chapter provided descriptions of the changes induced by the AMPs, MSI-78
(Figure 5.1) and BP100 (Figure 5.2), in the 2H NMR spectra of B. subtilis. This
is the first 2H NMR observation of the whole cell lipid membrane disruption by
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Table 5.2: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectrum of B. subtilis in the absence of AMP (average over six samples shown




M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
untreated samples) 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
20 3.5 3.7 1.20
BP100. This chapter also reports the first static 2H NMR observation of B. subtilis
in the presence of any AMPs. MSI-78 and BP100 were found to cause similar
changes in the membrane spectra. Those changes included a reduction of intensity
in the prominent edge region and a concomitant increase at narrow splittings.
While the AMP-induced disruption in the prominent edge region has been observed
in model membranes, the increase in intensity at narrower splittings has been, to
the best of my knowledge, observed only in the 2H NMR spectra of AMP-treated
whole bacterial cells, and not in model membranes. This would suggest that
there is a significant difference in how AMPs interact with membranes in bacteria,
as compared to their interaction with membranes in model lipid-only-systems.
As shown in Figure 5.1, in the case of MSI-78, the changes were concentration
dependent, i.e. more pronounced in the 20% than in the 10% MSI-78 treatment.
These characteristic changes in the spectra of AMP-treated B. subtilis were also
observed in E. coli JM109 in the presence of MSI-78.
The AMP-induced reduction in the prominent edges and the attendant increase
in intensity at narrower splittings were also reflected in the M1 and ∆2 values.
For both BP100 and MSI-78, there was an increase in ∆2 and a decrease in M1
associated with the presence of 20% wt/wt of AMP (see Table 5.1 for MSI-78 and
5.2 for BP100). The decrease in M1 and the increase in ∆2 indicate a lower mean
order parameter and a greater relative mean squared width of the order parameter
distribution. These changes are consistent with an increase in the disorder along
the whole acyl chain and a disruption in the lipid bilayer of the AMP treated
samples. 2.1
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5.3.1 Comparison of the effect of MSI-78 and BP100 on the
2H NMR spectra of deuterium-enriched B. subtilis.
In order to assess possible differences between the effects of MSI-78 and BP100 on
the B. subtilis membrane, 2H NMR spectra of B. subtilis in the presence of the
same concentrations of MSI-78 and BP100 were plotted together in Figure 5.3.















































Figure 5.3: Comparison of the changes in 2H NMR spectra of B. subtilis in-
duced by the presence of BP100 and MSI-78. Black: reference spectrum (NS53)
with no peptide; Red: with 20% BP100 (wt/wt): Blue: with 20% MSI-78
(wt/wt). (a): Absolute Intensity spectra. (b): Spectra normalized by area.
Samples were prepared using the protocol explained in Sections 3.2.2.3 and 3.5.
Dashed lines at ±12.5 kHz are shown to facilitate comparison of the spectra.
Each spectrum represents 32,000 scans recorded over eight hours at 37◦C in a
9.4 T NMR spectrometer.
Figure 5.3(a) shows the absolute intensity 2H NMR spectra and Figure 5.3(b)
the spectra normalized by area of B. subtilis in absence of AMP in black, in the
presence of 20% wt/wt BP100 in red, and in the presence of 20% wt/wt MSI-78
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in blue. Both AMPs caused similar changes in the 2H NMR spectra of B. sub-
tilis, i.e., a reduction of the prominent edges at ∼ ± 12.5 kHz, and an increase
of the intensity at smaller splittings. There appears to be no difference in the
spectral shape changes induced by the two peptides, suggesting that the changes
and membrane perturbations are not particular to either AMP and that analo-
gous quantities of MSI-78 and BP100 causes similar levels of perturbation. This
is particularly interesting since possible secondary targets have been suggested for
MSI-78 and BP100. In the case of BP100, an interaction of this AMP with the
LPS layer of Gram - bacteria and the lipoteichoic acid (LTA) of Gram - bacteria
have been reported [58, 101, 102] as well as an interaction of MSI-78 with the bac-
terial ribosomes [31]. Notice that the LPS and LTA are extracellular components
of the bacterial cell, and the ribosomes are located inside of the cell membrane.
Summarizing, MSI-78 and BP100 caused similar levels of perturbation in the bac-
terial membrane despite one having an intracellular secondary target and the other
one an extracellular secondary target. Both peptides are positively charged and
have similar hydrophobicity (as judged by the GRAVY index1 of -0.16 for MSI-78
and -0.19 for BP100). The charge difference alone may cause a difference in the
binding affinity to lipid bilayers of both peptides; however, both of them cause the
same lipid bilayer disruption at analog concentrations.
Table 5.3: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectrum of B. subtilis in the absence (average over six samples shown in Table




M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
untreated samples) 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
20 MSI-78 4.4 6.5 1.45
20 BP100 3.5 3.7 1.20
Table 5.3 shows the comparison of the M1, M2 and ∆2 values for the 2H NMR
spectrum of B. subtilis in the absence and presence of MSI-78 and BP100. Both
AMPs generated a reduction in the M1 and M2 as well as an increase in the ∆2
1GRAVY index (Grand Average of hydropathy) is a value used to measure the hydrophobicity
of peptides or proteins. Positive values indicate more hydrophobic structures and negative value
indicate more hydrophilic structures. Values close to 0 are typical of amphiphilic sequences.
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values. Considering that ∆2 is the relative mean square width of the distribution
of orientational order parameter, an increase in ∆2 is a result of the reduction of
the plateau region of the orientational order profile.
Chapter 6
Peptidoglycan Disruption Does not
Affect AMPs’ effects on 2H NMR
Spectra of B. subtilis Lipid Bilayer
The main goal of this project is to determine if the peptidoglycan (PGN) layer
in the bacterial cell envelope impacts the interaction between the bacterial lipid
membrane and two different AMPs, MSI-78 and BP100. The chosen research
approach included 1) assessing the changes in the 2H NMR spectra of B. subtilis
with the addition of MSI-78 and BP100 (Sections 5.1 and 5.2), 2) exploring possible
changes in the B. subtilis spectra caused by the disruption of the PGN layer
(Section 6.1.1), and 3) studying the B. subtilis spectra with the combination of a
compromised PGN layer and treatment with BP100 and MSI-78 (Section 6.2).
6.1 Disrupting the PGN layer of B. subtilis
Lysozyme is a 129 amino acid enzyme known for its ability to hydrolyze the PGN
layer of the bacterial cell wall. The lysozyme monomer can hydrolyze a specific
structural linkage of the polysaccharide copolymers that contribute to PGN rigid-
ity. Because the PGN is responsible for the stability of the bacterial shape under
hypertonic conditions, disruption of the PGN layer can result in cell lysis, i.e.
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breaking open the cell. Lysozyme is present in body fluids, secretions and tissues
of humans and animals due to its antibiotic properties [103]. Given the antimicro-
bial effect of lysozyme, and the objectives of this work, it was necessary to optimize
the lysozyme concentration and treatment time that disrupts the PGN without
causing lysis of the cell. In 2011, Muchová et al. reported work that included the
preparation of B. subtilis protoplasts [79]. Protoplasts include a Gram + bacteria
whose cell walls have been largely but not entirely removed [104]. The protocol
implemented by Muchová et al. uses lysozyme to remove the PGN layer in B.
subtilis followed by the resuspension of the cells in a sucrose-rich buffer to prevent
cell lysis due to osmotic pressure. While the goal of Muchová’s et al. protocol
was to remove, almost entirely, the PGN layer, my purpose was to induce only a
partial disruption of the PGN layer. Thus, Muchová’s et al. protocol was used as a
starting point to optimize the lysozyme concentration needed to partially degrade
the PGN layer in a fixed time of 10 minutes.
One of the easiest ways to observe the change in the PGN content in a bacterial cell
is Gram staining. Gram staining is a method that is frequently used to differentiate
Gram + and Gram - bacteria. Gram staining consists of a series of steps that
include staining with crystal violet, decolorization using 95% ethyl alcohol and
counterstaining with safranin. During the decolorization process, Gram + bacteria
get dehydrated which induces the pores of the cell wall to shrink, causing the
crystal violet to get trapped in the PGN layer and giving cells a purple colour. On
the other hand, the thin PGN layer of Gram - bacteria allows the crystal violet
to be washed away. This difference in the decolorization process causes Gram -
bacteria to only retain the safranin solution and to appear pink in the microscope.
The enzymatic disruption of the B. subtilis’ PGN layer leads it to also appear
pink after Gram staining.
Figures 6.1(a) and 6.1(b) shows the Gram staining of B. subtilis without lysozyme
treatment. Gram staining was performed using the protocol in Section 3.4. Figure
6.1(a) includes an approximate scale bar. As expected, the colour of the untreated
bacteria is purple and reflects an intact PGN layer. Figure 6.1(c) shows the Gram
staining of B. subtilis after being treated with 0.1 mg/ml lysozyme for 10 minutes.
The disruption of the PGN layer can be inferred from the change in the Gram
staining colour from purple to pink. Figure 6.1(d) shows the Gram staining of B.
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(a) (b)
(c) (d)
Figure 6.1: Gram staining change induced by different lysozyme treatments.
Gram staining of Bacillus subtilis treated with (a) and (b) 0 mg/ml, (c) 0.1
mg/ml and (d) 10 mg/ml of lysozyme for 10 minutes. Bacterial samples were
tested in different stages of the protocol resulting in pictures with different cell
concentration. Approximate scale bar represent 5 µm (see section 3.4).
subtilis after being treated with 10 mg/ml lysozyme for 10 minutes. In addition
to the change in the Gram staining colour, there are no observable rod-shape cells
after treatment with 10 mg/ml lysozyme, i.e. all the cells are roughly spherical.
This rounding-up indicated near-total removal of the PGN layer of B. subtilis, i.e.
the formation of B. subtilis protoplasts.
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6.1.1 Different lysozyme treatments do not change 2H NMR
spectra of B. subtilis
In order to explore the possible changes in the 2H NMR B. subtilis spectra caused
by the disruption of the PGN layer, spectra were obtained from samples treated
with a lysozyme concentration from 0.01 mg/ml to 10 mg/ml of lysozyme (Figure
6.2).

























































Figure 6.2: PGN disruption does not affect 2H NMR spectra of B. subtilis.
2H NMR spectra of B. subtilis enriched with deuterated acyl chains treated
with up to 10 mg/ml of lysozyme. (a): Absolute intensity spectra of B. subtilis
treated with 0 mg/ml, 0.01 mg/ml, 0.1 mg/ml, 1 mg/ml and 10 mg/ml. (b):
Spectra normalized by area. Dashed lines at ±12.5 kHz are included to facilitate
comparison of the spectra. Each spectrum represents 32,000 scans recorded over
eight hours at 37◦C in a 9.4 T NMR spectrometer.
Figure 6.2 shows spectra of B. subtilis treated with up to 10 mg/ml lysozyme, with
the absolute intensity spectra in panel a and the normalized spectra in b. Spectra
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of four different preparations treated with different concentrations of lysozyme us-
ing the protocol detailed in Section 3.3 are shown. All preparations exhibit similar
signal-to-noise ratios and prominent edges at ∼ 12.5 kHz. These prominent edges
indicate the persistence of the plateau region of the order parameter profile, which
suggests little or no disruption of the acyl chains of the bacteria with lysozyme
treatment alone. A low intensity spectral component between ∼ 12.5 and 62.5
kHz is present in all of the B. subtilis spectra and does not change with lysozyme
treatment. There is thus no spectroscopically-observable evidence of lysozyme
perturbing or disrupting the lipid bilayer of the bacterial membrane.
Table 6.1: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectrum of B. subtilis (average over six samples shown in Table 4.4) and B.
subtilis treated with different concentrations of lysozyme showed in Figure 6.2.
M1, M2 and ∆2 values for the untreated sample are an average over six samples,




M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over six
untreated samples) 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
0.01 8.7 15 0.49
0.1 7.6 12 0.53
1 8.8 16 0.50
10 8.6 15 0.51
Table 6.1 shows the values of the first and second moments,M1 andM2 along with
the ∆2 values for all the spectra shown in Figure 6.2. M1 values for the treated
samples were slightly larger than the average M1 of untreated samples but close
to the untreated sample with the highest M1, i.e. 7.9 × 104 s−1(See Table 4.4).
The 1 and 10 mg/ml treated samples had a higher M2 higher than the untreated
samples, but close to the untreated sample with the highest M2, i.e. 13 × 109
s−2 (See Table 4.4). The calculated ∆2 values for the treated samples were very
similar to the average of the untreated samples. The changes in the M2 values
are a result of the slightly increase in the M1 values but, ∆2 remains relatively
unchanged.
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In summary, lysozyme treatment does not appear to affect the lipid membrane
structure and dynamics at all. It is quite interesting to know that while PGN is
needed for cell envelope rigidity, disrupting it appears to have no effect on the
membrane structure and dynamics. To follow up on this observation, I carried out
experiments with lipids extracted from the bacteria to compare to intact bacteria
samples.
6.1.2 Comparing spectra of deuterated lipids in intact cells,
lysed cells and in lipids extracted from B. subtilis
A standard biochemical procedure can be used to extract the lipid component
of cells with non-polar organic solvents. Bacteria were prepared with deuterated
lipids as usual, and then the lipids extracted in this way. Extracted lipids were
dried and then resuspended in 2×YT media, to preserve the amount of salt in the
sample, as detailed in Section 3.6.
The red spectrum in Figure 6.3 shows the 2H NMR spectrum of the lipids extracted
from B. subtilis. The absolute intensity spectrum is shown in Figure 6.3(a) and the
spectrum normalized by area is shown in Figure 6.3(b). In Figure 6.3(b) the lipid
extract spectrum is compared with the 2H NMR spectrum of intact B. subtilis.
Both spectra display prominent edges at ∼ ± 12.5 kHz and similar signal-to-noise
ratios. It is only the spectrum of the whole cells, however, that exhibits intensity
out to frequencies of ∼ ± 62.5 kHz. Since this intensity is likely due to the bacteria
retaining and storing lipids in a gel like phase state, it is not surprising that this
spectral component is not present in the 2H NMR spectra of the lipids extracted
from B. subtilis.
Given how similar the spectra from the lipids alone and the lipids within the intact
cells are, I was also interested in how the spectra of cell lysate would look. For
this, the deuterated B. subtilis were broken open mechanically, via shear stress
(see section 3.6 for more details about french press process), but not treated with
any organic solvents.
The blue spectrum in Figure 6.3 shows the 2H NMR spectrum of B. subtilis cell
lysate. The absolute intensity spectrum is shown in Figure 6.3(a) and the spectrum
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Figure 6.3: 2H NMR spectra of B. subtilis: lipids prepared three ways. 2H
NMR spectra of Black: B. subtilis enriched with deuterated acyl chains. Red:
Lipids extract from B. subtilis enriched with deuterated acyl chains and Blue:
Cell lysate from B. subtilis enriched with deuterated acyl chains. (a): Absolute
intensity spectra. (b): Spectra normalized by area. Dashed lines at ±12.5 kHz
are included to facilitate comparison of the spectra. Each spectrum represents
32,000 scans recorded over eight hours at 37◦C in a 9.4 T NMR spectrometer.
normalized by area is shown in Figure 6.3(b). In Figure 6.3(b) the cell lysate
spectrum is compared with the 2H NMR spectrum of B. subtilis. Both spectra
display prominent edges at ∼ ± 12.5 kHz and similar signal-to-noise ratios.
Table 6.2 shows the values of the first and second moments,M1 andM2, along with
the ∆2 values for all the spectra shown in Figure 6.3. The difference in intensity
at the wide splittings out to ∼ ± 62.5 kHz between the samples is reflected by the
M1 and M2 values. The highest values of M1 and M2 were obtained from the cell
lysate sample and the lowest values from the lipid extract sample. The calculated
values of ∆2 for the lipid extract and cell lysate from B. subtilis are both slightly
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Table 6.2: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectra of B. subtilis (average over six samples shown in Table 4.4), lipids extract
from B. subtilis and cell lysate from B. subtilis showed in Figure 6.3.




6.2 ± 1 8.4 ± 3 0.59 ± 0.08
Lipid extract from
B. subtilis 5.1 5.3 0.47
Cell lysate from B.
subtilis 9.9 18.3 0.39
lower than the one reported for the whole cells. However, the differences are not
significant when compared with the changes caused by the AMPs.
6.2 The combined effects of PGN disruption and
treatment with AMPs on B. subtilis
After assessing the 2H NMR spectra of B. subtilis with a disrupted PGN layer,
the final stage of this project was to evaluate the impact of the disruption of the
PGN layer on the interaction between the bacterial lipid membrane and the AMPs
MSI-78 and BP100. To do so, I obtained the 2H NMR spectra of B. subtilis with
a partially disrupted PGN layer in the presence of AMPs. The effects of both
AMPs were observed with cells treated with two concentrations of lysozyme, 0.01
mg/ml and 0.08 mg/ml. The two concentrations of lysozyme correspond to two
levels of PGN disruption. In choosing these lysozyme concentrations, the goal
was to generate a PGN disruption without killing a substantial fraction of the
cells. Previous studies performed in our lab showed that lysozyme concentrations
above 0.09 mg/ml reduce greatly the fraction of cells alive and capable of forming
colonies [105].
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6.2.1 MSI-78
As discussed above, AMPs induce a concentration-dependent reduction in the
intensity from the plateau region, with a concomitant increase in the intensity at
narrow splittings. Concentrations higher than 20% of AMPs were not considered.
In addition to the two levels of disruption of the PGN layer, two concentrations
of MSI-78 were tested, 10% and 20% wt/wt.
6.2.1.1 10% MSI-78


















0.01 mg/mL Lys +










































Figure 6.4: Disruption of the PGN layer does not change the effect of 10%
MSI-78 on the 2H spectra of B. subtilis.(a): Absolute intensity spectra of Black:
cells treated with 0.01 mg/ml lysozyme for 10 min, Red: In presence of 10%
MSI-78 (wt/wt), Blue: In the presence of 10% MSI-78 (wt/wt) after being
treated with 0.01 mg/ml lysozyme for 10 min, Magenta: In the presence of 10%
MSI-78 (wt/wt) after being treated with 0.08 mg/ml lysozyme for 10 min. (b)
Spectra normalized by area. Dashed lines at ±12.5 kHz are shown to facilitate
comparison of the spectra. Each spectrum represents 32,000 scans recorded in
eight hours at 37◦C in a 9.4 T NMR spectrometer.
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Figure 6.4 shows the 2H NMR spectra of B. subtilis treated with lysozyme only
in black and with MSI-78 only in red. The spectra of the bacteria treated with
the combination of the two treatments are shown in blue, for cells treated with
0.01 mg/ml lysozyme and 10% MSI-78, and in magenta for cells treated with 0.08
mg/ml lysozyme and 10% MSI-78. Figure 6.4(a) shows the absolute intensity
spectra and Figure 6.4(b) the spectra normalized by area. A substantial reduction
of the prominent edges at ∼ ± 12.5 kHz and an increase in the intensity at the
narrow splittings was observed for all the AMP treated samples. As seen from the
superposition of the spectra at the top of Figure 6.4(b), the disruption of the PGN
layer with 0.01 mg/mL of lysozyme does not substantially change the effect of 10%
MSI-78 on the bacterial cell membrane. Nonetheless, a further disruption of the
PGN layer seems to generate changes in the effect of 10% MSI-78 on the bacterial
cell membrane 2H NMR spectrum. Those changes included more intensity at
narrow splittings (∼ ± 6 kHz) and less intensity at large splittings (∼ ± 20 kHz).
Table 6.3: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectrum of B. subtilis treated with lysozyme to induce partial disruption of the








M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
six samples) 0 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
0 0.01 8.7 15 0.49
0 0.1 7.6 12 0.53
10 0 6.1 10 0.92
10 0.01 6.7 11 0.82
10 0.08 3.3 2.1 0.45
In addition to the direct comparison between the control spectra with the AMP +
lysozyme treated spectra, M1, M2 and ∆2 values were obtained. Table 6.3 shows
the values of the first and second moments, M1 and M2, along with the ∆2 values
for all the spectra shown in Figure 6.4 and for the spectra of B. subtilis treated with
0.1 mg/ml lysozyme shown in Figure 6.2. The moment values (M1 and M2) of the
PGN compromised cells treated with 10% wt/wt MSI-78 vary considerably. M1
and M2 for 10% MSI-78 and 0.08 mg/ml lysozyme are somewhat smaller resulting
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from the increase of intensity at lower frequencies, the decrease of intensity at large
splittings and the asymmetry of the spectrum. More importantly, ∆2, which I and
others have found to be most diagnostic for AMP-induced changes [1, 6, 106] is
no different for this sample than for untreated cells. In this particular spectrum,
there is an observable asymmetry due to a slight mistuning of the Larmor frequency
before the experiment. Frequency tuning is difficult for samples containing AMP
because of the sharp edges tend to disappear and the large intensity at narrow
splittings gets superimposed onto the water peak. It is important to note that
even though ∆2 is sensitive to AMP-induced changes, it is also sensitive to the
spectral symmetry.
6.2.1.2 20% MSI-78
Figure 6.5 shows the 2H NMR spectra of B. subtilis treated with lysozyme only
in black and with MSI-78 only in red. The spectra of the bacteria treated with
the combination of the two treatments are shown in blue, for cells treated with
0.01 mg/ml lysozyme and 20% MSI-78, and in magenta for cells treated with 0.08
mg/ml lysozyme and 20% MSI-78. Figure 6.5(a) shows the absolute intensity
spectra and Figure 6.5(b) the spectra normalized by area. A substantial reduction
of the prominent edges at ∼ ± 12.5 kHz and an increase in the intensity at the
narrow splittings was observed for all the AMP-treated samples. As observed on
the top spectra in Figure 6.5(b), the disruption of the PGN layer does not enhance
or diminish the effect of 20% MSI-78 on the bacterial cell membrane.
Table 6.4 shows the values of the first and second moments, M1 and M2, along
with the ∆2 values for all the spectra shown in Figure 6.5 and the spectra of B.
subtilus treated with 0.1 mg/ml lysozyme shown in Figure 6.2. Two of the three
AMP-treated samples showed a decrease in M1 and M2 values. More importantly,
all the AMP-treated samples demonstrated an increase in ∆2 value, which enforces
the idea that ∆2 value is sensitive to the changes induced in the 2H NMR spectra of
bacterial cells treated with AMP. The combination of AMP and lysozyme resulted
in an increase in the calculated ∆2 values. However, the ∆2 values obtained for the
samples treated with lysozyme followed by 20% MSI-78 treatment were smaller
than the one obtained for the only-20% MSI-78 treated sample. The experiments
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Figure 6.5: Disruption of the PGN layer does not change the effect of 20%
MSI-78 on the 2H spectra of B. subtilis.(a): Absolute intensity spectra of Black:
cells treated with 0.01 mg/ml lysozyme for 10 min, Red: In presence of 20%
MSI-78 (wt/wt), Blue: In the presence of 20% MSI-78 (wt/wt) after being
treated with 0.01 mg/ml lysozyme for 10 min, Magenta: In the presence of 20%
MSI-78 (wt/wt) after being treated with 0.08 mg/ml lysozyme for 10 min. (b)
Spectra normalized by area. Dashed lines at ±12.5 kHz are shown to facilitate
comparison of the spectra. Each spectrum represents 32,000 scans recorded in
eight hours at 37◦C in a 9.4 T NMR spectrometer.
would need to be repeated to determine the significance of the observed difference.
In any case, if there are differences in the AMP-treated cell with and without PGN
disruptions, the differences are very small compared to the effect of AMP alone.
6.2.2 BP100
Figure 6.6 shows the 2H NMR spectra of B. subtilis treated with lysozyme only
in black and with 20% BP100 only in red. The spectra of the bacteria treated
with the combination of the two treatments are shown in blue, for cells treated
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Table 6.4: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectrum of B. subtilis treated lysozyme to induce partial disruption of the PGN








M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
six samples) 0 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
0 0.01 8.7 15 0.49
0 0.1 7.6 12 0.53
20 0 4.4 6.5 1.45
20 0.01 6.3 11 1.06
20 0.08 4.0 4.5 1.12
with 0.01 mg/ml lysozyme and 20% BP100, and in magenta for cells treated with
0.08 mg/ml lysozyme and 20% BP100. Figure 6.6(a) shows the absolute intensity
spectra and Figure 6.6(b) the spectra normalized by area. A substantial reduction
of the prominent edges at ∼ ± 12.5 kHz and an increase in the intensity at the
narrow splittings was observed for all the AMP treated samples. As observed in
the top spectra in Figure 6.6(b), the disruption of the PGN layer does not enhance
or diminish the effect of 20% BP100 on the bacterial cell membrane.
Table 6.5: M1, M2 and ∆2 values, as defined in section 2.3.2.1, for 2H NMR
spectra of B. subtilis treated with lysozyme to induce partial disruption of the








M1 ×104(s−1) M2 ×109(s−2) ∆2
0 (Average over
six samples) 0 6.2 ± 1 8.4 ± 3 0.59 ± 0.08
0 0.01 8.7 15 0.49
0 0.1 7.6 12 0.53
20 0 3.5 3.7 1.20
20 0.01 3.7 4.4 1.30
20 0.08 6.1 10.5 1.08
Table 6.5 shows the values of the first and second moments, M1 and M2, along
with the ∆2 values for all the spectra shown in Figure 6.6 and the spectrum of B.
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Figure 6.6: Disruption of the PGN layer does not change the effect of 20%
BP100 on the 2H spectra of B. subtilis.(a): Absolute intensity spectra of Black:
cells treated with 0.01 mg/ml lysozyme for 10 min, Red: In presence of 20%
BP100 (wt/wt), Blue: In the presence of 20% BP100 (wt/wt) after being treated
with 0.01 mg/ml lysozyme for 10 min, Magenta: In the presence of 20% BP100
(wt/wt) after being treated with 0.08 mg/ml lysozyme for 10 min. (b) Spectra
normalized by area. Dashed lines at ±12.5 kHz are shown to facilitate compar-
ison of the spectra. Each spectrum represents 32,000 scans recorded in eight
hours at 37◦C in a 9.4 T NMR spectrometer.
subtilus treated with 0.1 mg/ml lysozyme shown in Figure 6.2. Two of the three
AMP-treated samples showed a decrease in M1 and M2 values. All the AMP-
treated samples showed an increase in the ∆2 values demonstrating again, that
∆2 value is sensitive to the changes induced in the 2H NMR spectra of the bacteria
by AMP. There were small increases in M1 and M2 for the combined treatment as
compared to the AMP treatment alone, but the effects were small and may just
reflect normal sample-to-sample variation.
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6.3 Discussion
In this chapter I show that disrupting the peptidoglycan layer has no major impact
on the lipid disordering effects of AMPs MSI-78 and BP100. This finding is borne
out by comparison of the 2H NMR spectra of B. subtilis treated with MSI-78 or
BP100 with and without a disrupted PGN layer. Additionally, lysozyme treatment
itself has no effect on lipid order, as shown by Figure 6.2 which shows 2H NMR
spectra B. subtilis of five samples treated with concentrations of lysozyme between
from 0.01 mg/ml up to 10 mg/ml.
All lysozyme-treated spectra display similar characteristics including prominent
edges at ∼ ± 12.5 kHz. The prominent edges reflect the plateau region of the
order parameter profile and indicate that the lipid bilayer is in a liquid-crystalline
phase. The lack of observable differences between the spectra from the lysozyme-
treated and untreated samples indicates that lysozyme does not interact directly
with the lipid bilayer of the bacteria at lysozyme concentrations up to 10 mg/ml.
Additionally, the 2H NMR spectra suggest that disrupting the PGN layer of the
B. subtilis cell envelope does not affect the order parameter profile, indicating no
change in the structure or dynamics of the lipid bilayer. One reason this result is
quite interesting is because changes in lipid domains in the membrane of Gram +
bacterial cells with a disrupted PGN have been observed using fluorescence and
immunofluorescence microscopy [79, 107]. However, as discussed in section 4.5.3,
small lipid domains cannot be observed during the timescale of a 2H NMR mea-
surement. The absence of an effect of PGN disruption on AMP-induced changes
observable directly in the spectra is also supported by the ∆2 values calculated
from the spectra (Table 6.1), which remain similar to the values of the non-treated
samples.
In order to investigate the role of the PGN layer and the rest of the cell on the
2H NMR spectra of B. subtilis, the spectra of intact cells were compared with the
spectra of lipids extracted from the cells and with the spectra of mechanically
lysed cells (Figure 6.3). Given the lipid extraction procedure (Section 3.6), the
sample containing the lipids extracted from B. subtilis is expected to form giant
multilamellar vesicles (GMV) filled with just media but without the PGN layer
and without most of the membrane proteins. On the other hand, the sample
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consisting of untreated cells contains cells with an intact PGN layer. Finally, the
lysed cell sample contains cells broken open mechanically, presumably generating
a heterogeneous mixture of all the cell components. This sample may contain
multilamellar bilayer structures, probably with embedded proteins. The french
press process is however, expected to break apart the PGN layer. In summary, the
untreated B. subtilis sample contains an intact PGN layer, the cell lysate sample
contains fragments of the PGN web and the lipids extracted from the cells contain
no PGN at all.
As observed in Figure 6.3, all three samples produce spectra that indicate lipids
forming bilayers in a liquid-crystalline phase. Interestingly, all samples reflect
similar structure and dynamics regardless of the PGN condition or the absence of
the PGN layer. The formation of lipid bilayer structures with dynamical properties
similar to the intact cells even after mechanically breaking open the cells makes
sense because lipid bilayers are self assembling. This lipid bilayer "reconstructing"
process apparently occurs even in a protein crowded environment. Significantly,
when compared with the 2H NMR of lysed cells, the spectra of AMP treated cells
(Figures 4.2, 5.1 and 5.2) looks very different. Thus, AMPs induce a structural
modification of the bilayer structure that is dramatically different from that of
even very harsh treatments such as organic extraction or mechanical lysis. It is
important to mention that, given the observations from the 2H NMR spectra of
lysed B. subtilis cells and the cell viability experiment presented by Pius et al.
[6], it seems that if the cell membranes of dead cells remains intact. 2H NMR
spectroscopy is unable to report differences between death or alive cells. Cell
viability experiments of B. subtilis under conditions identical to those used in the
NMR experiments would be necessary to fully interpret this observation.
The effect of the PGN disruption on the activity of MSI-78 and BP100 in B.
subtilis was assessed by comparing the 2H NMR spectra of B. subtilis treated
with MSI-78 or BP100, with the spectra of cells treated with lysozyme followed
by MSI-78 or BP100. Figure 6.4 showed no significant difference between all the
spectra of B. subtilis treated with 10% MSI-78, regardless of the condition of the
PGN layer. The three AMP-treated spectra all lack prominent edges at ∼ ± 12.5
kHz and show an increase in the intensity at the narrow splittings as compared
to cells without AMP. Similar behaviour was observed in the spectra of B. subtilis
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treated with 20% MSI-78 (Figure 6.5) and 20% BP100 (Figure 6.6) regardless of
whether the PGN layer was intact or disrupted.
These findings directly relate to a current open discussion in the AMP field about
whether PGN promotes accumulation of AMPs on the cell membrane or, instead,
entraps the AMPs thus preventing them from reaching the cell membrane [12].
This work includes one previous study that tried to address the role of the PGN
on the activity and functionality of the AMPs OP-145 and LL-37 [108], the results
of which will be compared with mine below after addressing the literature more
specific to MSI-78 and BP100.
The results presented in Figures 6.5 and 6.6 show that disrupting the PGN does
NOT affect AMPs’ abilities to disrupt the lipid bilayer, at least for MSI-78 and
BP100. One point to note is that, in addition to their cell lysis activities, MSI-
78 has a known intra-cellular target, ribosomes, and BP100 has non-lipid extra-
cellular target, LPS in Gram - and LTA in Gram + bacteria [58, 101, 102]. It is
possible that membrane lysis is not the main antimicrobial mechanism for these
two peptides and is just incidental to their other mechanism. However, it is not
clear how possessing non-lytic activities would relate to the indifference of the
AMP-induced lipid disruption to the presence of intact PGN. None-the-less, the
data indicate that the PGN layer does not interact with MSI-78 and BP100 in a
way that either sensitizes or protects the cells from AMP-induced bilayer disrup-
tion as previously suggested [12, 23, 108, 109].
There has been some experimental work done on the role of PGN in the effect of
lysozyme on AMP treatment. Experiments monitoring the leakage of fluorescent
dyes out of vesicles caused by OP-145 and LL-37 showed that the presence and
absence of 0.1 wt % PGN did not affect the membrane permeability [110]. The
authors suggested these findings can be explained because entrapping of AMP
molecules will not occur for most AMPs, due to the porosity of the PGN to
small molecules the same size as AMPs [12]. Additionally, they suggest that the
PGN does not reduce the concentration of positively charged AMPs on the cell
membrane since PGN is not negatively charged. The findings of Malanovic et
al. [110] agree with my findings that MSI-78 and BP100 cause the same level of
membrane disruption in cells with an intact and compromised PGN layer.
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Perhaps AMPs with an affinity to the PGN layer would present a different re-
sponse to the one observed here and by Malanovic et al. [108]. In order to obtain
a better understanding, additional 2H NMR studies could be done with eosinophi-
cilin cationic protein (ECP) and oxiganan, two peptides with strong partitioning
toward PGN [111–114].
In contrast to my BP100 work, other publications DID find evidence of permeabi-
lization enhancement with a combined treatment of BP100 and lysozyme in Gram
- bacteria [59]. In a 2017 study, Cabrefiga et al. measured MIC concentration in
addition to cell membrane permeabilization with flow cytometry and fluorescence
microscopy of Erwinia amylovora cells in the presence of SYTOX green. Cabre-
figa et al. observed a permeabilization enhancement with the combined treatment
of BP100 and lysozyme in comparison with the treatment of lysozyme or BP100
alone. This permeabilization enhancement also resulted in a reduction of the MIC
concentration. Two important differences between my protocol and the Cabrefiga
et al. protocol are that I treated with lysozyme BEFORE AMP, whereas Cabre-
figa et al. treated with lysozyme and AMP at the same time and, I worked Gram
+ B. subtilis while Cabrefiga et al. used Gram -. Moreover, Gram - bacteria have
an outer bacterial membrane composed of LPS among other lipids, that lysozyme
cannot penetrate and thus Gram - bacteria tend to be less susceptible to lysozyme
than Gram + bacteria. Given that BP100 interacts with the LPS layer on Gram
- cells [58, 61, 102, 115], such as Erwinia amylovora, the AMP might permeabilize
the outer bacterial membrane enabling the lysozyme greater access to the PGN
layer. Thus, BP100 might generate a susceptibility of Gram - cells to lysozyme as
a result of the BP100-LPS interaction.
Further studies reported combined treatments of lysozyme and specific AMPs as a
more effective way to kill Gram + and Gram - bacteria in comparison with treating
bacteria with lysozyme or AMPs alone [116–118]. Even though my protocol is
different from the ones followed by Zdybicka-Barabas et al., Chai et al. and Lee et
al., because I treated with lysozyme before AMPs, these studies are still relevant to
understanding the interplay of AMP and lysozyme interactions with cell envelope
components.
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In 2012, Zdybicka-Barabas et al. reported an increase in the antimicrobial effec-
tiveness of the anionic peptide 2 (GMAP2) when Gram - E. coli or K. pneumo-
niae cells were treated at the same time with lysozyme [116]. Zdybicka-Barabas
et al. used β-galactosidase measurements to determine cell membrane perforation
and AFM and SEM imaging to determine the cell surface alterations caused by
lysozyme and anionic peptide 2 (GMAP2). That study reported an increase in the
level of perforation of E. coli in the presence of lysozyme as well as cell envelope
surface alterations caused by GMAP2 in E. coli and K. pneumoniae [116]. The
authors suggested the possibility of formation of an intermolecular complex be-
tween the AMP and lysozyme that would increase the antimicrobial effectiveness
of both molecules. However they also suggest that this complexation does not
occur in solution without a cell membrane present.
In addition, two further studies reported synergistic action of the AMP nisin with
lysozyme in Gram + bacteria [117, 118]. Both studies were performed in Clostrid-
ium difficile and track the antimicrobial effect of nisin, lysozyme and the combina-
tion of nisin+lysozyme. Note that even though nisin is classified as an AMP, it can
only disrupt negatively charged membranes at peptide concentrations much higher
than those necessary for bacterial killing or if the membranes contain lipid II [119].
The results showed that the antimicrobial effect of the mixture of lysozyme+nisin
was faster than the antimicrobial effect of nisin or lysozyme alone. Since nisin
belongs to the family of lantibiotics which are peptides capable of inhibiting PGN
biosynthesis, the action of lysozyme+nisin on Gram + bacteria would result in a
faster antimicrobial effect since both components attack the PGN layer, generat-
ing cell lysis. However, there was no indication of the cell membrane being more
disrupted because of the mixture. In fact, since nisin has an extracellular target,
it is probable that the mixture is not causing more membrane disruption than the
AMP alone.
In sumary, Zdybicka-Barabas et al., Chai et al and Lee et al reported an improve-
ment in the bactericidal effect of GMAP2 and nisin in the presence of lysozyme
[116–118]. However, these studies were intended to demonstrate lysozyme poten-
tiation of AMP activity, NOT to address the role of PGN in AMP activity. Fur-
thermore, only Chai et al and Lee et al used Gram + bacteria for their studies.
Therefore, to the best of my knowledge, my thesis work represents one of the first
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studies directed at understanding the role of the PGN layer in the AMP-disruption
of lipid bilayers.
Chapter 7
Conclusions and Future Directions
As laid out in Section 2.2, it is necessary to build a bridge that connects the
historical work regarding antimicrobial peptides (AMPs) interacting with model
lipid bilayers to the relatively recent finding that at least some AMPs act on non-
lipid targets. The main focus of this thesis was to study the importance of the
peptidoglycan (PGN) layer, one of the non-lipid components of the bacterial cell
envelope, in the interaction of the AMPs with lipids of the membrane. To do so,
the strategy chosen was to use a technique commonly used to study model lipid
systems, 2H NMR, but apply it to whole bacteria.
The overall research goal, to use 2H NMR of intact cells to study the importance
of PGN in AMP-lipid interactions, was accomplished by way of four objectives.
The first objective was the characterization of the 2H NMR spectra of B. subtilis.
The second study was to study the changes in the spectra in the presence of AMPs
MSI-78 and BP100. The third objective was to look for possible changes in the
B. subtilis spectra caused by PGN disruption alone. Finally, B. subtilis spectra
were obtained for samples with both a compromised PGN layer and treatment
with MSI-78 or BP100.
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7.1 Disruption of the bacterial membrane ofB.subtilis
caused by MSI-78 and BP100
One of the most important conclusions of this work was that MSI-78 and BP100
induced changes in the 2H NMR spectra of B. subtilis that indicate disruption of
the lipid bilayer structure corresponding to an increase in lipid disorder (Figures
5.1 and 5.2). This is important since only a few 2H NMR studies of whole cell
have been reported since 1975 [1, 6, 8, 68, 75, 106, 120, 121] and only four of them
investigated the effect of AMPs on the structure and dynamics of the lipid bilayer
[6, 8, 106, 121]. While the earlier whole cell 2H NMR work focussed on Gram - bac-
teria, this thesis provides the first characterization of the static 2H NMR spectra of
deuterium-rich Gram + B. subtilis (Figure 4.3), as well as the characterization of
E. coli JM109 spectra (Figure 4.2) and LA8 spectra (Figure 4.1). Addition of the
AMPs MSI-78 and BP100 was seen to substantially affect the 2H NMR spectra of
intact bacteria. Additionally, the changes to the spectral shape induced by MSI-
78 are similar to the changes induced by BP100. The AMP-induced disruption
in whole cells consists of the disappearance of the sharp edges at ∼ ± 12.5 kHz,
along with a concomitant increase in intensity at narrow splittings. The formation
of toroidal pores is the most likely mechanism of membrane disruption that might
explain the changes observed in this study. This type of membrane disruption
has been suggested for other AMPs in previous NMR studies [89–91]. This inter-
pretation would agree with previous studies suggesting that MSI-78 and BP100
can form toroidal pores [48, 49, 102, 122]. Additionally, while the AMP-induced
reduction in the sharp edges has been observed in model lipids experiments, the
increase in intensity at narrow splittings has not being observed in model lipids in
the presence of AMPs [48, 83–88]. This difference of the AMP-induced changes in
the 2H NMR spectra of whole cells versus model systems suggests a difference in
how AMPs interact with membranes in bacteria, as compared to their interaction
with membranes in model-lipid-only systems. Most likely, this difference is due
to the complex structure and composition of the bacterial envelope however, it
is possible that this difference is due to the complex lipid composition of the cell
membrane only. One strategy to test this idea would be to compare the changes
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induced in the spectra by the AMPs between whole cells, lipid extract and cell
lysate, as a part of the future research directions.
At 20% wt/wt concentration, MSI-78 and BP100 show the same level of cell mem-
brane disruption (Figure 5.3). A brief review of the physicochemical properties
of both peptides shows that MSI-78 and BP100 are positively charged, MSI-78’s
charge at pH 7 is +10 and BP100 +6. There is no apparent difference in the hy-
drophobicity of both peptides as judged by their GRAVY indices1. It is interesting
that the difference in charge does not lead to a difference in membrane disruption.
Perhaps hydrophobic interactions contribute to the binding energy enough so that
there is no difference in AMP-bilayer binding, even with the difference in charge
and consequently, electrostatic interactions. Future research directions include
obtaining MIC concentrations for both AMPs in B. subtilis and comparing the
level of cell membrane disruption of two antimicrobial peptides with an evident
difference in the hydrophobicity but similar charges.
It was somewhat surprising that both MSI-78 and BP100 lead to a similar level
of membrane disruption, given their difference in charge and the important role
charge interactions are supposed to play in AMP mechanisms. It was thus in-
triguing to find in the literature that, both MSI-78 and BP100 have potential
non-lipid, i.e. secondary, targets. The interaction of BP100 with the lipopolysac-
charides (LPS) layer of Gram - bacteria and the lipoteichoic acid (LTA) of Gram
+ bacteria has been reported [101, 102] as well as the interaction of MSI-78 with
the ribosomes [31]. Considering that the LPS and the LTA are components of the
bacterial cell wall, i.e., located outside of the cell membrane, and the ribosomes
are in the cytoplasm, i.e., located inside of the cell membrane, it is intriguing that
both AMPs display the same level of lipid bilayer disruption at analogous wt/wt
ratios.
Finally, since the molar bound peptide to lipid ratio (P:L) is an important ref-
erence when describing the antimicrobial activity of AMPs, an estimation of the
bound P:L was performed for MSI-78. The estimated molar bound P:L ratio in
my experiments at 20% MSI-78 is 0.94:1, as calculated using the same rationale
1GRAVY index (Grand Average of hydropathy) is a value used to measure the hydrophobicity
of peptides or proteins. Positive values indicate more hydrophobic structures and negative value
indicate more hydrophilic structures. Values close to 0 are typical of amphiphilic sequences.
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described by Pius et al.[6]. It was assumed that 100 % of the AMPs are bound
to the bacteria, that lipids compromise the 5.2 % of the bacterial dry weight of
B. subtilis [123], and that lipids have an average molecular weight of 705 g/mol.
A bound P:L ratio of 0.94:1 is far below the bound P:L ratios needed to inhibit
bacterial growth (∼ 100:1), i.e. the ratio at the MIC concentration [16]. Note
that the P:L ratio necessary to generate lipid bilayer disruption and leakage in
model systems is ∼ 1:100 (See appendix A) [16] i.e. ∼ 100 times less AMP than in
my work. At least in terms of P:L ratio, the NMR samples are prepared with an
amount of AMP expected to be sublethal. Since the level of membrane disruption
was substantial even at P:L ratios of ∼ 1:1, it it impressive that bacteria are able
to survive this much damage to their membranes.
7.2 A Weakened PGN layer did not change the 2H
NMR spectra of B. subtilis
Another main finding of this work is that the disruption of the PGN layer in B.
subtilis did not change the 2H NMR spectra. To achieve a compromised PGN
layer, different concentrations of lysozyme were tested. Lysozyme is an enzyme
able to hydrolyze the PGN layer of Gram + bacteria. A severe disruption of the
PGN layer can cause cell lysis since this layer is, among other things, responsible
for maintaining the osmotic pressure balance and cell shape. Thus, in order to
keep the cells from breaking open, the lysozyme treatment of the cells was done in
sucrose rich media that prevents the osmotic pressure imbalance (see section 3.3).
The disruption of the PGN layer in B. subtilis was confirmed using a microscope,
thanks to the change in the Gram staining of the lysozyme-treated cells from purple
to pink (Figures 6.1(b), 6.1(c) and 6.1(d)). In addition, the severe disruption of
the PGN layer induced a change in B. subtilis cell shape from rod to spherical
shape that was observed in the microscope.
Despite the noticeable change in the B. subtilis cell wall and shape caused by
the treatment with up to 10 mg/mL of lysozyme, it was striking that the 2H
NMR spectra (Figure 6.2) showed no change in the structure or lipid order of the
cell membrane. Previous fluorescence and immunofluorescence microscopy studies
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reported changes in the lipid domains of the cell membrane of Gram + bacteria
with a disrupted PGN layer [79, 107]. However, small lipid domains can not be
observed during the timescale of a 2H NMR measurement (see section 4.5.3).
Previous studies reported a non-enzymatic mechanism of action for lysozyme
[105, 124]. This non-enzymatic mechanism of action includes the binding and
membrane disruption caused by lysozyme. This non-enzymatic mechanism has
been reported by Acreman [105] using heat denatured lysozyme (DN-Lyz) and by
Ibrahim et al. [124] using a D52S lysozyme mutant whose aspartic acid at position
52 was substituted with serine (D52S-Lyz). DN-Lyz and D52S-Lyz were devoid of
enzymatic activity but, both were still able to kill Gram + bacteria, specifically
B. subtilis. To help assess the relevance of the lysozyme non-enzymatic mecha-
nism of action to my experiments, the molar lysozyme to lipid ratios (Lyz:L) of
Acreman, Ibrahim et al., and my B. subtilis experiments were estimated. The
bacterial dry weight was calculated using cell concentrations reported by Acre-
man and Ibrahim et al. (2.5×105 [105] and 2×106 cells/mL [124] respectively),
Acreman’s relationship between the Colony Forming Unit (CFU) per mL and the
absorption at 600 nm (A600) (y = (1.4211 × 108)A600 [105]), and my relationship
between bacterial dry weight and A600 from section 3.5.1. Finally, it was assumed
that lipids compromise 5.2 % of the bacterial dry weight and that the lipids have
an average molecular weight of 705 g/mol. The estimated Lys:L ratios were 4.3:1
for Ibrahim et al., 7.8:1-13:1 for Acreman and 1:25000 - 1:2.5 for my experiments.
The Lys:L ratio in my experiments was much smaller than in the other studies
and thus lysozyme is unlikely to have a direct effect on the membrane. This is
consistent with the lack of change in 2H NMR spectra of B. subtilis with lysozyme
treatment (Figure 6.2).
A very interesting observation in this study was how different were the 2H NMR
spectra of bacterial cells treated with AMPs (Figures 4.2, 4.3, 5.1 and 5.2) com-
pared to the spectra of mechanically lysed cells (Figure 6.3). The spectra of the
mechanically lysed cells show the formation of lipid bilayer structures with similar
dynamical properties to the intact cell spectra. On the other hand, the spectra of
bacterial cells treated with AMPs reflect a change in the order parameter profile
that is consistent with a disrupted lipid bilayer with highly curved structural fea-
tures. Thus, the "lytic" effect of the AMPs is the result of an active AMP-lipid
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bilayer interaction that prevents the cell membrane from being restored, contrary
to the mechanically lysed cells, where lipid bilayer structures rapidly self-repair.
There must be something very special about what AMPs do to the membranes.
At this point it is important to remark that 2H NMR spectroscopy of bacterial
cells reports about the lipid bilayer state and not into the viability of the cells.
For example, as shown in Figure 6.3, the 2H NMR spectrum of lysed B. subtilis
is not different from the spectra of live B. subtilis because the membranes from
cells that were mechanically disrupted were able to reassemble with time. On the
other side, the cell viability experiment presented by Pius et al. showed that the
spectral shape obtained from E. coli LA8 samples remained unchanged after 12 to
18 hours of measurements despite a cell viability reduction of approximately 50%
[6].
7.3 Level of cell membrane disruption caused by
MSI-78 and BP100 in B. subtilis does not
change even with a compromised PGN layer
The final part of my thesis work directly addresses an important question that,
to my knowledge, has not been addressed before. There has been an ongoing
discussion about whether the PGN layer of bacterial cells promotes accumulation
of AMPs on the cell membrane or, instead, entraps the AMPs preventing them
from reaching the lipid bilayer [12, 108]. However, only a few studies provide some
insights about this specific topic. In this study I have shown that MSI-78 and
BP100 cause the same level of cell membrane disruption regardless of the PGN
layer state (Figures 6.5 and 6.6). This observation derives from the comparison of
the 2H NMR spectra of B. subtilis treated with MSI-78 or BP100 and the spectra
of B. subtilis treated with lysozyme and MSI-78 or BP100. At least for these two
AMPs in B. subtilis, PGN has no effect on their membrane-disrupting activities.
While my work focussed on intact cells, other researchers have come at PGN
and AMP interaction using simple model systems. In their study, Malanovic et
al. showed that the presence and absence of 0.1 wt % PGN did not affect the
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membrane permeability induced by OP-145 and LL-37 [110]. These findings in
MSI-78, BP100, OP-145 and LL-37 suggests that the PGN is not promoting the
accumulation of AMPs. Perhaps this is because there is no electrostatic interaction
between the AMP and the PGN and because the PGN layer is relatively permeable
to particles smaller than 2 nm [12]. As part of the future research directions, it
could be interesting to examine similar 2H NMR studies in Gram + bacteria in the
presence of peptides like eosinophicilin cationic protein (ECP) or oxiganan, two
peptides whose strong affinity towards the PGN layer has been measured before
[111–114]. Perhaps, those AMPs would display a different response to the one
observed with MSI-78, BP100, OP-145 and LL-37.
There is a group of studies where the antimicrobial effect of lysozyme+AMP mix-
tures was compared with the antimicrobial effect of lysozyme or AMPs alone.
These studies reported synergistic action of AMPs with lysozyme in Gram + bac-
teria [117, 118] and in Gram - bacteria [59, 116] as a result of a combined treatment.
While Chai et al. [117], Lee et al. [118], and Cabrefiga et al. [59] intended to
reinforce the antimicrobial effect of the AMP with a combined lysozyme+AMP
treatment, Zdybicka-Barabas et al. [116] intended to study the antimicrobial ef-
fect of two of the hemolymph (insect blood) components at the same time. More
details about these studies are part of section 6.3. There are four significant dif-
ferences between these studies and mine. First, these studies are NOT intended
to study the role of the PGN in the activity of the AMP. Second, only Cabrefiga
et al. studied an AMP used in my studies [59]. Third, none of these studies were
performed in B. subtilis and just two used Gram + bacteria. Fourth, the protocols
from all of these studies differ from mine since I did not study the effect of a com-
bined Lysozyme+AMP treatment. Rather, the AMP treatment was carried out
in centrifuged samples after the lysozyme treatment. The studies performed by
Cabrefiga et al., Zdybicka-Barabas et al., Chai et al. and Lee at al indicate that
the combination of lysozyme+AMP leads to an improvement over the antimicro-
bial capacity of the AMP alone [59, 116–118]. However, it is not clear from these
works if lysozyme action against PGN is helping the AMP disrupt the membrane,
or if another mechanism is involved. Consequently, my study is the first research,
performed in whole cells, about the role of the PGN in the AMP-disruption effect
in the cell membrane.
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In addition to the existing debate about whether the PGN layer of bacterial cells
promotes accumulation of AMPs on the cell membrane or, instead, entraps the
AMPs preventing them from reaching the lipid bilayer, there is similar debate
about whether teichoic acids (TAs) (section 2.1.4) promote or hinder the inter-
action of AMPs with the cell membrane [12, 116–118]. Unlike PGN, TAs pos-
sess an overall negative charge and, thus, might have stronger interactions with
AMPs [125, 126]. The interaction between positively charged AMPs and nega-
tively charged TAs could lead to two opposite outcomes. The first possibility is
that the AMPs may get trapped by the lipoteichoic acids (LTAs) and wall teichoic
acids (WTAs) reducing the number of peptide molecules that actually bind to the
cell membrane. This might result in just a fraction of the AMPs reaching the
cell membrane and causing membrane disruption. On the other hand, the second
possibility is that the AMPs may be using the TAs as a poly-anionic ladder in
order to reach the cell membrane i.e., the TAs might mediate the entry of the
AMPs towards the cell membrane.
Evidence of LTA possibly reducing the effective AMP concentration on the cell
membrane include studies in model systems like Malanovic et al. and Liu et al.
[110, 127] and in whole bacteria [127]. In 2013, Wen et al. showed that pre-
incubating the AMP β-bungarotoxin B chain with LTA resulted in reducing the
AMP’s permeabilization of PG/CL vesicles, indicating that some of the AMP
bound to the LTA and was sequestered from the lipid vesicles [127]. In addi-
tion, Malanovic et al. showed a reduction in OP-145 penetration capacity in
POPG/LTA vesicles in comparison with pure POPG vesicles [110]. Both studies
indicate that β-bungarotoxin B chain and OP-145 interact with LTA resulting in
an attenuation of the lipid bilayer permeabilization of both peptides. Similarly,
Wen et al. showed that β-bungarotoxin B chain demonstrated bactericidal activity
against Gram + S. aureus only when the bacterial cells were treated with rifampin
before the AMP treatment. Given that rifampin is a LTA biosynthesis inhibitor,
the authors concluded that the inhibition of LTA biosynthesis in S. aureus made
the cells prone to AMP damage [127]. Assuming that the LTA is reducing the
effective AMP concentration on the cell membrane, it suggests that the absence
or reduction of LTA would increase the bactericidal effect of the AMP.
On the other hand, evidence of TAs acting like a poly-anionic ladder helping
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promote AMP’s access to the cell membrane was presented by Koprivnjak et al.
[128]. In their study, the authors showed how the S. aureus tagO mutant was
selectively resistant to two AMPs, the mammalian group II phospholipase A2
(gIIA PLA2) and the human β-defensin 3. Since the tagO mutant of S. aureus
lacks WTA, Koprivnjak et al. suggested that the AMPs were lacking the initial
rung of the poly-anionic ladder which would prevent them AMPs from reaching
the cell membrane [128].
During my experiments, I partially removed the PGN layer of the B. subtilis cell
wall during that process. In doing so it is likely that I also removed some of the
WTAs linked to the PGN. It is also possible that lysozyme is also hydrolyzing
the LTAs directly. In any case, if, as seems likely, the lysozyme treatment also
disrupted the LTA, this did not change the level of lipid membrane disruption
caused by the positively charged MSI-78 and BP100. This lack of effect could be
because the disruption of the TAs is too gentle or because LTAs do not affect the
ability of MSI-78 or BP100 to affect the lipids. As part of future research, it could
be interesting to examine if the disruption of the electrostatic interactions between
AMPs and TAs generate a change in the level of disruption caused by the AMPs.
In conclusion, I have shown that the addition of MSI-78 and BP100 leads to a
decrease in the order parameter of the cell membrane acyl chains consistent with
cell membrane disruption. Also, the disruption of the PGN layer of B. subtilis
does not affect its 2H NMR spectra. Finally, the disruption of the PGN does NOT
affect the abilities of MSI-78 and BP100s to disrupt the lipid bilayer.
Appendix A
Numerical Calculations
A.1 Peptide to lipid ratio calculations
A.1.1 P:L ratios for 20% and 10 % MSI-78 (wt/wt) used in
this work
The molar peptide to lipid ratio (P:L) is an important reference when describing
the antimicrobial activity of AMPs. The difference in the P:L ratios between
model system studies and sterilization experiments is one of the reasons for us
to think that the non-lipid components of the bacterial cell envelope may play a
role in the AMP-bacteria interaction. The molar amounts of lipid for the AMP-
treated samples were calculated from the bacterial dry weight, knowing that the
lipids comprise 5.2% of the bacterial dry weight [123]. For example, the sample
treated with 20% MSI-78 (wt/wt) had an absorbance at 600 nm of 0.783. From
the absorbance vs bacterial dry weight relationship explained in 3.5.1, a bacterial
dry weight of 211 mg was obtained. Then, the approximated lipid mass was 11
mg. The average molecular weight of the lipids was 705 g/mol, from which was
determined that this sample in particular had 1.6 ×10−5 moles of lipids.
For this sample, an MSI-78 fraction of 20% (wt/wt) required 42 mg of peptide.
Since the molecular weight of MSI-78 is 2478.2 g/mol, this corresponded to 1.7
×10−5 moles of peptides for this sample.
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In conclusion, the molar P:L ratio for the sample treated with 20% MSI-78 (wt/wt)
was 1.7:1.6 or 1:0.94. A similar calculation was performed for the 10% MSI-78
(wt/wt) sample leading to a molar P:L ratio of 1:1.8.
A.1.2 Molar P:L ratio calculations for biological studies
In order to corroborate the estimate of P:L molar ratios for biological experiments
reported in the 2010 review by Wimley [16], P:L ratio were obtained from the
MIC values reported from three recent biological studies [61, 129, 130]. Each of
these studies was performed in different bacterial species using different AMPs.
All the data from these studies used for the calculation of the molar P:L ratio are
reported in Table A.1.
Table A.1: Reported MIC results








SP1-1 6.25 1565.07 1.1 [61]
E. coli BP100 2-4 1421.88 0.3 [129]
B. subtilis rLH 1.9 3947.84 0.2-0.7 [130]
To estimate the amount of lipids in each sample, the number of colony forming
units (CFU) per unit of volume (See Table A.1) was multiplied by the number of
lipids per cell strain. The number of lipids per cell strain was calculated as the ratio
between the volume of the lipid bilayer and the approximate volume of a lipid ∼
1.4 × 10−9 µm3. In order to calculate the volume of the lipid bilayer of each strain
multiple considerations were made. For example, Staphylococcus aureus cells were
approximated to spheres of 0.5 µm of radio [131] with a peptidoglycan structure 24
nm width [132]. E. coli cells were considered as rods of 1 µm wide and 2µm long
[133] with two lipid bilayers of the same thickness and a peptidoglycan structure
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4.2 nm width [134]. Finally, B. subtilis cells were considered as rods of 0.84 µm
wide and 2.8 µm long [135] with a peptidoglycan structure 50 nm width [136].
Table A.2: P:L molar ratios for corresponding to reported MIC




Staphylococcus aureus SP1-1 6.25 [61] 8.07 400:1
E. coli BP100 2-4 [129] 26.6 250:1
B. subtilis 1.9 rLH [130] 17.8 150:1
Table A.2 shows the approximated P:L molar ratios for three AMPs SP1-1, BP100
and rLH calculated from MICs reported in different studies [61, 129, 130]. The
calculated P:L molar ratios are within one order of magnitude of the P:L molar
ratio for biological studies estimated by Wimley in 2010 [16].
A.2 Dry Weight uncertainty calculations
The bacterial dry weight of each sample was calculated from the absorbance at 600
nm and using the experimentally calculated relationship ln(DryWeight(mg))=(1.3±
0.1)A600+(4.3± 0.1) for E.coli JM109 or ln(DryWeight(mg))=(1.3± 0.3)A600+(4.3±
0.2) for B. subtilis. The dry weight, q, can thus be written in terms of the ab-
sorbance, x, as q = eAx+B where A and B are the slopes and intercepts of the lines
in Figures 3.1. If it is assumed that all of the uncertainty in q is associated with
uncertainty in the calibration of the absorbance conversion, the uncertainty in q














In this case x is the absorbance at 600 nm i.e. x = A600. Then
δq =
√







(xδA)2 + δB2. (A.3)
In the case of an absorbance of x = 0.75 of a B. subtilis culture, the calculated
value calculated dry weight is 200 mg, the relative uncertainty (δq/q) is 0.3 and
the absolute uncertainty (δq) is 60 mg.
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